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Abstract: Lipopeptide biosurfactants (LPBSs) consist of a hydrophobic fatty acid portion 
linked to  a hydrophilic peptide chain in the molecule. With their complex and diverse 
structures, LPBSs exhibit various biological activities including surface activity as well as 
anti-cellular  and  anti-enzymatic  activities.  LPBSs  are  also  involved  in  multi-cellular 
behaviors such as swarming motility and biofilm formation. Among the bacterial genera, 
Bacillus  (Gram-positive)  and  Pseudomonas  (Gram-negative)  have  received  the  most 
attention because they produce a wide range of effective LPBSs that are potentially useful 
for  agricultural,  chemical,  food,  and  pharmaceutical  industries.  The  biosynthetic 
mechanisms and gene regulation systems of LPBSs have been extensively analyzed over 
the last decade. LPBSs are generally synthesized in a ribosome-independent manner with 
megaenzymes called nonribosomal peptide synthetases (NRPSs). Production of active-form 
NRPSs  requires  not  only  transcriptional  induction  and  translation  but  also 
post-translational modification and assemblage. The accumulated knowledge reveals the 
versatility  and  evolutionary  lineage  of  the  NRPSs  system.  This  review  provides  an 
overview of the structural and functional diversity of LPBSs and their different biosynthetic 
mechanisms  in  Bacillus  and  Pseudomonas,  including  both  typical  and  unique  systems. 
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Finally,  successful  genetic  engineering  of  NRPSs  for  creating  novel  lipopeptides  is 
also discussed. 
Keywords:  lipopeptide  biosurfactants  (LPBSs);  nonribosomal  peptides;  nonribosomal 
peptide synthetases (NRPSs) 
 
1. Introduction 
Biosurfactants  are  biological  surface-active  compounds  largely  produced  by  a  wide  variety  of 
microorganisms.  They  have  environmentally  friendly  properties,  such  as  low  toxicity  and  high 
biodegradability. Biosurfactants are capable of lowering surface and interfacial tensions effectively and 
thus are potential substitutes for widely used chemically synthesized surfactants. Thus, biosurfactants 
show  promise  for  use  in  agricultural,  food,  pharmaceutical,  cosmetic,  specialty  chemical,  and  oil 
production  industries  as  well  as  in  bioremediation  technology.  The  hydrophobic  portion  of  these 
molecules is commonly made up of fatty acids (saturated, unsaturated, or hydroxylated), whereas the 
hydrophilic portion is usually composed of peptides or mono-, di-, or polysaccharides [1]. Due to the 
presence of hydrophobic and hydrophilic moieties within a single molecule, (bio)surfactants tend to 
migrate  toward  an  interface  with  different  degrees  of  polarity  and  hydrogen  bonding,  such  as  an 
air/water or oil/water interface [2].  
Production of effective lipopeptide biosurfactants (LPBSs) was first reported from Gram-positive 
Bacillus subtilis IAM1213 [3]. Since then, various types of LPBSs with significant surface activity 
and/or  anti-microbial  activity  have  been  isolated  from  other  Bacillus  strains [4–7].  Gram-negative 
Pseudomonas spp. also produce a variety of LPBSs  [8–12]. Gene clusters encoding multi-modular 
nonribosomal peptide synthetases (NRPSs) for LPBS production have been cloned and characterized 
from these two genera, and demonstrate their different evolutionary lineages. The systematic modular 
organization of NRPSs allows structural alteration of lipopeptides by swapping domains or modules of 
NRPSs to create novel lipopeptides [13,14]. This article aims to summarize current knowledge of the 
structural diversity of LPBSs and their biosynthetic systems in the genera Bacillus and Pseudomonas. 
Current possibilities and limits in the modification of their biosynthetic genes for the synthesis of novel 
compounds are also discussed. 
2. Diversity of LPBSs and NRPSs from Bacillus and Pseudomonas  
Bacillus and Pseudomonas spp. produce a wide range of LPBSs (Tables 1, 2). These lipopeptides 
share similar amphipathic structures containing both a hydrophilic peptide portion and a hydrophobic 
fatty acid  portion.  Most of the LPBSs  have a cyclic structure mediated by the linkage between a 
C-terminal peptide residue and either a β-hydroxy fatty acid, hydroxyl group of the peptide residue, or 
β-amino acid. NRPSs are multi-modular enzymes that recognize, activate, modify, and link the amino 
acid intermediates to the product peptide [15]. They are capable of synthesizing peptides that contain 
unusual amino acids including D-amino acids, -amino acids, and hydroxy- or N-methylated amino 
acids. Biosynthesis of nonribosomal peptides occurs via the function of the catalytic unit, referred to as Int. J. Mol. Sci. 2011, 12                       
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a module. The order of modules is usually co-linear to the product peptide sequences (Figure 1). Each 
module  is  composed  of  specific  domains  that  are  responsible  for  catalyzing  different 
enzymatic activities. 
The  adenylation  (A)  domain  is  responsible  for  amino  acid  recognition  and  adenylation  at  the 
expense of ATP to form an acyl-adenylate intermediate. Then, the adenylated amino acid covalently 
binds to a phosphopantetheine carrier of the adjacent thiolation (T) or peptidyl carrier protein (PCP) 
domain.  Peptide  bond  formation  of  two  consecutively  bound  amino  acids  is  catalyzed  by  the 
condensation (C) domain. Modification domains, such as the epimerization (E) domain, catalyze the 
conversion  of  L-amino  acids  to  D-isomers,  and they are typically associated with  the module that 
incorporates D-amino acids. Lastly, cyclization and release of the product peptide are carried out by 
C-terminal thioesterase (Te) domain that is associated with a termination module. A number of gene 
clusters encoding NRPSs for LPBS biosynthesis in both Bacillus and Pseudomonas have been cloned 
and characterized (Figure 1). These gene clusters show striking similarities in the modular architecture 
of their repetitive catalytic units and assembly-line mechanism. However, several unique features have 
also been identified. 
2.1. Bacillus 
Most LPBSs from Bacillus can be classified into three families: surfactin, fengycin, and iturin [16]. 
There  are  several  Bacillus  strains  that  have  the  ability  to  produce  three  families  of  LPBSs 
simultaneously  [17–20]. In addition to these three families, several other lipopeptides have also been 
identified in Bacillus species (Table 1). Characteristics of these LPBSs families and corresponding 
NRPSs are as follows. 
2.1.1. Surfactin and Lichenysin Synthetases  
Surfactin  and  lichenysin  are  structurally  related  LPBSs  produced  by  B.  subtilis  and  
B. licheniformis  [3,7,21]. Several other forms of surfactin with amino acid variation at position 2, 4, 
and 7 have been reported  [22]. Surfactin carries strong surfactant properties by reducing the surface 
tension of water from 72 to 27 mN/m at a critical micelle concentration (CMC) of 25–220 mg/L 
depending  on  its  variants  and  determined  conditions   [3,23].  A  surfactin-like  compound  termed 
lichenysin  is  at  least  a  2-fold  more  efficient  biosurfactant  than  surfactin,  probably  due  to  the 
replacement  of  Glu1  by  Gln1 [6,23].  Surfactin  was  first  identified  as  an  inhibitor  of  fibrin  clot 
formation.  It  also  exhibits  anti-microbial,  anti-tumor,  anti-viral,  and  hemolytic  properties [24]. 
Surfactin is required for the biofilm formation of producing cells [25,26], swarming motility [27,28], 
and fruiting body formation [29]. However, surfactin also inhibits biofilm formation of other bacteria 
by interfering with attachment of the cells to surfaces [30]. Int. J. Mol. Sci. 2011, 12                       
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Table 1. Primary structure of representative lipopeptides produced by Bacillus strains. 
Name  Structure  Ref. 
Surfactin family     
Surfactin  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Leu   [31] 
Lichenysin A/D  FA-β-OH-L-Gln-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Ile   [7,32] 
(Lichenysin B)  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Leu   [33] 
(Lichenysin C)  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Ile   [34] 
Lichenysin G  FA-β-OH-L-Gln-L-[A2]-D-Leu-L-[A4]-L-Asp-D-Leu-L-[A7] 
A2 = Leu/Ile, A4 = Val/Ile, A7 = Ile/Val 
 [6] 
Surfactant BL86  FA-β-OH-L-Glx-L-Leu-D-Leu-L-Val-L-Asx-D-Leu-L-[A7] 
A7 = Ile/Val  
 [35] 
Pumilacidin  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Leu-L-Asp-D-Leu-L-[A7] 
A7 = Ile/Val  
 [36] 
Fengycin family     
Fengycin  FA-β-OH  
-L-Glu-D-Orn-D-Tyr-D-aThr-L-Glu-D-[A6]-L-Pro-L-Gln-L-Tyr-L-Ile 
A6 = Ala/Val 
 [37] 
Plipastatin  FA-β-OH  
-L-Glu-D-Orn-L-Tyr-D-aThr-L-Glu-D-[A6]-L-Pro-L-Gln-D-Tyr-L-Ile 
A6 = Ala/Val 
 [37] 
Iturin family     
Iturin A  FA-β-NH2-L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser   [38] 
Iturin C  FA-β-NH2-L-Asp-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Ser   [37] 
Bacillomycin L   FA-β-NH2-L-Asn-D-Tyr-D-Asn-L-Ser-L-Glu-D-Ser-L-Thr   [39] 
Bacillomycin D  FA-β-NH2-L-Asn-D-Tyr-D-Asn-L-Pro-L-Glu-D-Ser-L-Thr   [37] 
Bacillomycin F  FA-β-NH2-L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Asn-L-Thr   [37] 
Mycosubtilin  FA-β-NH2-L-Asn-D-Tyr-D-Asn-L-Gln-L-Pro-D-Ser-L-Asn   [40] 
Other     
Antiadhesin  FA-β-OH-L-Asp-L-Leu-L-Leu-L-Val-L-Val-L-Glu-L-Leu   [41] 
Bamylocin A  FA-β-OH-X-Glu-X-Leu-X-Met-X-Leu-X-Pro-X-Leu-X-Leu   [42] 
Circulocin 1  gFA-β-OH-X-Thr-X-Phe-X-Ile-X-Dba-X-Asp   [43] 
Circulocin 3  gFA-β-OH-X-Thr-X-Leu-X-Ile-X-Thr-X-Asn-X-Ala   [43] 
Fusaricidin  gFA-β-OH-L-Thr-D-Val-L-Tyr-D-aThr-D-Asn-D-Ala   [44] 
Kurstakins  FA-X-Thr-X-Gly-X-Ala-X-Ser-X-His-X-Gln-X-Gln   [45] 
 
These LPBSs are usually a mixture of compounds with different lengths and types of fatty acid 
(FA), β-hydroxy FA (FA-β-OH), β-amino FA (FA-β-NH2) or guanidylated-β-OH FA (gFA-β-OH). The 
β-OH or β-NH2 group of FA forms an ester or peptide bond with the carboxyl group of the C-terminal 
amino acid. For fengycin, circulocins, fusaricidin, and kurstakin, the carboxyl group of the C-terminal 
amino acid is lactonised with the hydroxyl group of Tyr3, Thr1, Thr1, and Ser4, respectively. 
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Table 2. Primary structure of representative lipopeptides produced by Pseudomonas. 
Group/Name  Structure  Ref. 
Viscosin
A     
Viscosin  FA-β-OH-L-Leu-D-Glu-D-aThr-D-Val-L-Leu-D-Ser-L-Leu-D-Ser-L-Ile   [46] 
Viscosinamide  FA-β-OH-L-Leu-D-Gln-D-aThr-D-Val-L-Leu-D-Ser-L-Leu-D-Ser-L-Ile   [47] 
Massetolide A  FA-β-OH-L-Leu-D-Glu-D-aThr-D-aIle-L-Leu-D-Ser-L-Leu-D-Ser-L-Ile   [48] 
Pseudophomin A  FA-β-OH-L-Leu-D-Glu-D-aThr-D- Ile-D-Leu-D-Ser-L-Leu-D-Ser-L-Ile   [49] 
Pseudodesmin A  FA-β-OH-L-Leu-D-Gln-D-aThr-D-Val-D-Leu-D-Ser-L-Leu-D-Ser-L-Ile   [50] 
Syringomycin
B      
Syringomycin A  FA-β-OH-L-Ser-D-Ser-D-Dab-L-Dab-L-Arg-L-Phe-Z-Dhb-L-Asp(3-OH)-L-Thr(4-Cl)   [51] 
Syringostatin A  FA-β-OH-L-Ser-D-Dab-L-Dab-D-Hse-L-Orn-L-aThr-Z-Dhb-L-Asp(3-OH)-L-Thr(4-Cl)   [52] 
Syringotoxin B  FA-β-OH-L-Ser-D-Dab-L-Gly-D-Hse-L-Orn-L-aThr-Z-Dhb-L-Asp(3-OH)-L-Thr(4-Cl)   [53] 
Pseudomycin A  FA-β-OH-L-Ser-D-Dab-L-Asp-D-Lys-L-Dab-L-aThr-Z-Dhb-L-Asp(3-OH)-L-Thr(4-Cl)   [54] 
Cormycin A  FA-β-OH-L-Ser-D-Orn-L-Asn-D-Hse-L-His-L-aThr-Z-Dhb-L-Asp(3-OH)-L-Thr(4-Cl)   [55] 
Amphisin
A      
Arthrofactin  FA-β-OH-D-Leu-D-Asp-D-aThr-D-Leu-D-Leu-D-Ser-L-Leu-D-Ser-L-Ile-L-Ile-L-Asp   [56] 
Amphisin  FA-β-OH-D-Leu-D-Asp-D-aThr-D-Leu-D-Leu-D-Ser-L-Leu-D-Gln-L-Leu-L-Ile-L-Asp   [10] 
Lokisin  FA-β-OH-D-Leu-D-Asp-D-aThr-D-Leu-D-Leu-D-Ser-L-Leu-D-Ser-L-Leu-L-Ile-L-Asp   [11] 
Pholipeptin  FA-β-OH-D-Leu-L-Asp-L- Thr-D-Leu-D-Leu-D-Ser-D-Leu-D-Ser-D-Leu-L-Ile-D-Asp   [12] 
Tensin  FA-β-OH-D-Leu-D-Asp-D-aThr-D-Leu-D-Leu-D-Ser-L-Leu-D-Gln-L-Leu-L-Ile-L-Glu   [57] 
Putisolvin
C     
Putisolvin I  CH3(CH)4CO-D-Leu-D-Glu-D-Leu-D-Ile-D-Gln-D-Ser-D-Val-D-Ile-D-Ser-L-Leu-L-Val-X-Ser   [58] 
Putisolvin II  CH3(CH)4CO-D-Leu-D-Glu-D-Leu-D-Ile-D-Gln-D-Ser-D-Val-D-Ile-D-Ser-L-Leu-L-Xle-X-Ser   [58] 
Tolaasin
A     
Tolaasin I  FA-β-OH-Dhb-Pro-Ser-Leu-Val-Ser-Leu-Val-Val-Gln-Leu   -        -      -      -    Val-Dhb-aThr-Ile-Hse-Dab-Lys   [59] 
Fuscopeptin  FA-β-OH-Dhb-Pro-Leu-Ala-Ala-Ala-Ala-Val-Gly-Ala-Val-Ala     -      -      -     Val-Dhb-aThr-Ala-Dab-Dab-Phe   [60] 
Corpeptin  FA-β-OH-Dhb-Pro-Ala-Ala-Ala-Val-Val-Dhb-Hse-Val-aIle-Dhb-Ala-Ala-Ala-Val-Dhb-aThr-Ala-Dab-Ser-Ile   [61] 
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Table 2. Cont. 
Syringopeptin
A     
SP22  FA-β-OH-Dhb-Pro-Val-Val-Ala-Ala-Val   -      -       -    Val-Dhb-Ala-Val-Ala-Ala-Dhb-aThr-Ser-Ala-Dhb-Ala-Dab-Dab-Tyr   [62] 
SP25  FA-β-OH-Dhb-Pro-Val-Ala-Ala-Val-Leu-Ala-Ala-Dhb-Val-Dhb-Ala-Val-Ala-Ala-Dhb-aThr-Ser-Ala-Val-Ala-Dab-Dab-Tyr   [63] 
SP25[Phe25]  FA-β-OH-Dhb-Pro-Val-Ala-Ala-Val-Leu-Ala-Ala-Dhb-Val-Dhb-Ala-Val-Ala-Ala-Dhb-aThr-Ser-Ala-Val-Ala-Dab-Dab-Phe   [64] 
Other     
Entolysin
D  FA-β-OH-D-Xle-D-Glu-D-Gln-D-Val-D-Xle-D-Gln-D-Val-D-Xle-D-Gln-D-Ser-L-Val-L-Xle-D-Ser-X-Xle   [65] 
Ofamide
A  FA-β-OH-L-Leu-D-Glu-D-aThr-D-aIle-L-Leu-D-Ser-L-Leu-L-Leu-D-Ser-L-Val   [66] 
Pseudofactin
A  CH3(CH)14CO-X-Gly-X-Ser-X-Thr-X-Leu-X-Leu-X-Ser-X-Leu-X-Leu/Val   [67] 
Syringafactin
E  FA-β-OH-D-Leu-D-Leu-D-Gln-L-Leu-D-Thr-L-Val-D-Leu-L-Leu   [68] 
A The hydroxyl group of aThr or Thr form an ester bond with the carboxyl group of the C-terminal amino acid 
B The hydroxyl group of L-Ser1 form an ester bond with the carboxyl group of the C-terminal amino acid 
C The hydroxyl group of D-Ser9 form an ester bond with the carboxyl group of the C-terminal amino acid 
D The hydroxyl group of D-Ser10 form an ester bond with the carboxyl group of the C-terminal amino acid 
E Linear lipopeptide Int. J. Mol. Sci. 2011, 12                       
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Figure  1.  Multidomain  organization  of  the  gene  clusters  encoding  NRPSs  from 
Bacillus (A) and Pseudomonas (B). 
(A) 
 
(B) 
 
 
The biosynthetic gene clusters of surfactin [69] and lichenysin [32], namely srfA and lic, are highly 
homologous  and  extend  over  25  kb  (Figure  1).  They  contain  four  open  reading  frames  (ORFs),  
srfA-A/licA, srfA-B/licB, srfA-C/licC, and srfA-Te/lic-Te. The amino acid sequences of the first three 
ORFs  are  homologous  to  other  NRPSs  whereas  the  last  ORF  encodes  a  putative  type  II  Te.  
SrfA-A/B/C and LicA/B/C are composed of three, three, and one module(s), and each ORF can be 
further subdivided into functional domains. SrfA and Lic bear six typical C-domains that catalyze Int. J. Mol. Sci. 2011, 12                       
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amide  bond  formation.  An  additional  C-domain,  the  N-acyl  domain,  is  located  at  the  N-terminal 
domain of the first module, suggesting that the first amino acid is initially N-acylated with a β-hydroxy 
fatty acid in this domain [32,70]. Recently, Kraas and coworkers (2010) have shown that the N-acyl 
domain  in  SrfA  transfers  CoA-activated  3-hydroxy  fatty  acid  to  the  first  T-domain  where  the 
N-terminal  Glu  is  bound [71].  SrfA  and  Lic  contain  the  conventional  E-domains  essential  for  the 
transformation of L-amino acids to D-amino acids and a C-terminal type I Te-domain that releases the 
final product. In addition to the C-terminal type I Te-domain, SrfA and Lic have an external type II Te 
protein, SrfA-Te/LicTe. A decreased production of surfactin (84%) is observed in the SrfA-Te mutant [72]. 
The external  type II Te is  involved in  regenerating misprimed T-domains  by removing short acyl 
chains  from  the  4'-phosphopantetheine  cofactors  and  thereby  regenerates  functional  NRPSs [73]. 
Moreover, a study has suggested that the type II Te also hydrolyzes incorrectly loaded amino acids that 
are  not  processed  by  the  nonribosomal  machinery [74].  SrfA-Te  also  functions  as  the 
thioesterase/acyltransferase that supports and stimulates the formation of β-hydroxymyristoyl-glutamate, an 
initiation substrate of surfactin synthesis [75,76]. 
2.1.2. Fengycin Synthetase 
Fengycin,  also  referred  to  as  plipastatin  when  Tyr3  and  Tyr9  is  present  as  the  L-and  D-form, 
repectively. It is an anti-fungal antibiotic that inhibits filamentous fungi but is ineffective against yeast 
and  bacteria.  It  is  also  capable  of  inhibiting  phospholipase  A2  and  biofilm  formation  of  several 
bacteria [4,37,77,78]. These types of lipodecapeptides are produced by various strains of Bacillus spp. 
and exhibit moderate surfactant activities [4,17,79]. Fengycin is expected to form a lactone between 
the hydroxyl group of L-Tyr3 and the C-terminal carboxyl group of L-Ile. Fengycin synthetase (Fen) 
contains five NRPS subunits: FenC (287 kDa), FenD (290 kDa), FenE (286 kDa), FenA (406 kDa), 
and FenB (146 kDa). Like SrfA and Lic, Fen is also composed of an N-acyl domain at the N-terminus 
of FenC, conventional E-domains, and a typical type I Te-domain. Fen assembles to form a co-linear 
chain ordered as FenC-FenD-FenE-FenA-FenB [80]. 
2.1.3. Bacillomycin, Iturin, and Mycosubtilin Synthetases 
The  iturin  family  comprises  bacillomycin,  iturin,  and  mycosubtilin,  which  are  cyclic 
lipoheptapeptides linked by a β-amino acid residue. Members of this family have strong antibiotic 
activity, moderate surfactant activity, and enhanced swarming motility [17,38,81]. The NRPS gene 
cluster of bacillomycin D (bam/bmy), mycosubtilin (myc), and iturin A (itu) is composed of four large 
ORFs [18,40,82,83].  bam  and  bmy  are  identical  gene  clusters  found  in  B.  subtilis  AU195  and 
B. amyloliquefaciens FZB42, respectively. The gene encodes multifunctional hybrid enzymes of a fatty 
acid  synthase,  an  aminotransferase,  and  peptide  synthetases.  The  first  ORF-bmyD,  ituD,  and 
fenF-encodes malonyl-CoA transacylase. The second ORF-bmyA, ituA, and mycA-encodes acyl-CoA 
ligase,  acyl  carrier  protein  (ACP),  β-ketoacyl  synthetase  and  aminotransferase  domains  before  a 
conventional  module  of  NRPS.  The  MycA  loading  module  activates  free  fatty  acids  through  an 
acyl-adenylate intermediate and loads on the adjacent ACP1 domain [84]. Meanwhile, FenF reveals 
broad  acyl-substrate  specificity  and  loads  malonyl-CoA  onto  ACP2  in  MycA [85].  The 
aminotransferase domain catalyzes the transfer of an amino group to the β-position of the growing acyl Int. J. Mol. Sci. 2011, 12                       
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chain [86]. The resulting β-amino fatty thioester is then presumably passed on to the third and fourth 
ORFs that encode four and two functional modules of a typical NRPS, respectively. Mycosubtilin and 
iturin A have almost the same structure except that D-Ser6 and L-Asn7 residues in mycosubtilin are 
inverted to D-Asn6 and L-Ser7 in iturin A. Amino acid sequence homology between the two A-domains 
for Ser and Asn in the two synthetases is high, suggesting that an intragenic domain change occurred in 
either Myc or Itu synthetase to evolve a counterpart gene [82]. 
2.1.4. Fusaricidin Synthetase 
Fusaricidin is a unique hexapeptide linked to guanidylated β-hydroxyl fatty acid that possesses a 
potent  anti-fungal  activity  produced  by  Paenibacillus  polymyxa  PKB1  (formerly  called  
Bacillus polymyxa). It is a candidate for a biocontrol medicine used to treat blackleg disease [44]. 
Fusaricidin synthetase (FusA) comprises six NRPS modules that are encoded by a single ORF. The 
second, fourth, and fifth, modules of FusA incorporate D-amino acids and carry E-domains. However, 
no E-domain was detected in the sixth module that would incorporate D-Ala [44].  
To date, three different mechanisms have been reported for incorporation of D-amino acids in the 
LPBS products. In the typical NRPS system in Gram-positive bacilli, an E-domain responsible for 
epimerization of L-amino acids to the D-forms is located downstream of D-amino acid-incorporating 
modules.  A  second  mechanism  is  the  direct  incorporation  of  D-amino  acids  by  the  respective 
A-domains.  This  system  is  found  in  eukaryotic  fungal  NRPS  systems  such  as  cyclosporine  and 
HC-toxin [87,88]. A third system for incorporating D-amino acid is a novel type of C-domain with dual 
epimerization and condensation activities (C/E domain), which has recently been identified in several 
NRPSs in both actinomycete and Gram-negative pseudomonads [89]. 
Regarding  FusA  synthetase,  two  different  mechanisms  for  incorporation  of  D-amino  acids  are 
employed. Conversion from L- to D-amino acid in the three modules of FurA synthetase is mediated by 
conventional E-domains, whereas direct incorporation of D-Ala is found in the last module that does 
not contain the E-domain or C/E domain [44]. Thus, horizontal gene transfer has potentially occurred 
between Gram-positive bacterial and fungal NRPS genes. 
2.2. Pseudomonas 
Pseudomonas  also  produces  a  variety  of  cyclic  lipopeptides.  Recently,  lipopeptides  of 
pseudomonads  have  been  classified  into  six  groups:  viscosin,  syringomycin,  amphisin,  putisolvin, 
tolaasin, and syringopeptin [90]. In addition to these six main LPBS groups, other lipopeptides have 
been also identified in Pseudomonas species, but no cyclic lipopeptides linked by a β-amino acid 
residue have been reported (Table 2).  
2.2.1. Syringomycin Synthetase 
Syringomycin is a phytotoxin and a key determinant of Pseudomonas syringae B301D virulence. It 
has  moderate  surfactant  activity  with  a  CMC  of  1250  mg/L  and  minimum  surface  tension  of 
33 mN/m [91]. Syringomycin is synthesized by two NRPSs (SyrB1, SyrE) and three modifying protein 
systems  (SyrB2,  SyrC,  SyrP).  SyrB1  and  SyrE  do  not  follow  the  co-linearity  rule  and  also  lack Int. J. Mol. Sci. 2011, 12                       
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E-domains. Eight modules for the first eight amino acids in SyrE are arranged in a line, but the ninth 
module (SyrB1), which is necessary for incorporation of the last amino acid (L-Thr9), is located in the 
upstream region [51]. This observation suggests that absolute co-linearity is not essential for NRPS 
synthesis, which is similar to SrfA data [92].  L-Thr9 is activated and loaded by SyrB1 and is then 
chlorinated  to  4-Cl-L-Thr  by  the  non-heme  Fe(II)  halogenase  SyrB2 [93].  This  intermediate  is 
transferred  from  the  T-domain  of  SyrB1  to  SyrE  by  aminoacyltransferase  SyrC  to  form  the  final 
product [94]. Hydroxylation of Asp at module 8 is catalyzed by SyrP, whose gene is located upstream 
of syrB1 [95]. Although three amino acid residues in syringomycin are in the D-form, the E-domain is 
not associated with the modules incorporating the respective  D-amino acids. However, Balibar and 
coworkers (2005) demonstrated that SyrE contains unique dual C/E domains, which contribute to the 
conversion of L-amino acids to the D-form [89]. 
2.2.2. Syringopeptin Syntheatase 
P.  syringae  B301D  also  produces  another  class  of  lipodepsipeptide  phytotoxins  called 
syringopeptin. Syringopeptin contains a larger peptide moiety than syringomycin, with 22 or 25 amino 
acid residues, and is one of the largest LPBS ever reported. Syringopeptin has a CMC of 820 mg/L and 
reduces surface tension to 40.2 mN/m [91]. Three NRPSs, SypA, SypB, SypC, are involved in the 
biosynthesis of syringopeptin. The order and number of the modules are co-linear to the amino acid 
sequence of syringopeptin SP22. SypA/B/C represents the largest NRPSs among those reported for 
prokaryotes. Similar to Syr synthetase, no E-domain is present in Syp synthetase, despite the presence 
of several  D-amino acids.  In contrast to the Syr synthetase, SypC contains two unique  C-terminal  
Te-domains predicted to catalyze the release and cyclization of syringopeptin [96].  
2.2.3. Arthrofactin Synthetase 
Arthrofactin  is  a  cyclic  lipoundecapeptide  produced  by  Pseudomonas  sp.  MIS38,  which  was 
initially misidentified as Arthrobacter sp. [56], and belongs to the amphisin group. The molecule is 
cyclized through the formation of an ester bond between the carboxyl group of the C-terminal Asp and 
the β-hydroxyl group of D-allo-Thr [97]. Arthrofactin is one of the most effective cyclic LPBSs; it 
reduces the surface tension of water from 72 to 24 mN/m with a CMC of 13.5 mg/L [56]. Arthrofactin 
appears to be essential for swarming activity and inhibits initial attachment of the planktonic cells in 
biofilm formation [98]. Several arthrofactin-like compounds with remarkable biosurfactant and anti-
fungal properties or an enzyme inhibitor have been reported from Pseudomonas spp. [9–12,57]. Like 
arthrofactin, amphisin is involved in swarming motility of Pseudomonas sp. DSS73 [99]. 
Biosynthesis of arthrofactin is catalyzed by the arthrofactin synthetase (Arf), which consists of three 
NRPS protein subunits, ArfA (234 kDa), ArfB (474 kDa), and ArfC (648 kDa), which contain two, 
four, and five functional modules, respectively (Figure 2) [98]. An additional C-domain was identified 
in the first module of ArfA, suggesting that the first amino acid could be initially acylated with a fatty 
acid. Site-directed mutagenesis changing the histidine residue of conserved core motif (HHXXXDG) 
to  alanine  impairs  arthrofactin  production [100].  This  result  suggested  that  the  first  C-domain  is 
essential for biosynthesis of lipopeptide. Indeed, the β-hydroxydecanoyl thioester may be coupled to 
the activated leucine by the action of this C-domain to yield β-hydroxydecanoyl-L-Leu as the initial Int. J. Mol. Sci. 2011, 12                       
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intermediate. A phylogenetic tree showed that the first C-domain of Arf belongs to N-acyl groups that 
use  fatty  acyl-CoA  as  their  starter  unit [70].  Although  seven  of  the  11  amino  acid  residues  in 
arthrofactin  are  in  the  D-form,  Arf  contains  no  E-domains,  as  found  in  syringomycin  and 
syringopeptin [98].  The  A-domain of  D-Leu1 specifically recognizes  only  L-Leu in vitro. Based on 
these  observations,  we  initially  hypothesized  that  an  external  racemase  may  be  responsible  for 
incorporation of the D-amino acids in arthrofactin. Different amino acid sequences downstream of a 
conserved  core  motif  [FFELGGHSLLA(V/M)]  in  the  T-domains  were  expected  to  reflect  the 
recognition  by  external  racemase.  However,  Balibar  and  coworkers  later  demonstrated  that  Arf 
contains  unique  dual  C/E  domains,  which  contribute  to  the  conversion  of  L-amino  acids  to  the 
D-form [89]. This novel C/E domain is cryptically embedded with the C-domain located downstream 
of the D-amino acid–incorporating modules. Dual C/E domains can be recognized by an elongated His 
motif (HHI/LXXXXGD). This feature was also identified in the Syr and Syp synthetases. Another 
unique characteristic of Arf is the presence of C-terminal tandem Te-domains like syringopeptin. By 
site-directed  mutagenesis,  the  first  Te-domain  (ArfC-Te1)  was  shown  to  be  essential  for  the 
completion of macrocyclization and the release of the final product. The second Te-domain (ArfC-Te2) 
was suggested to be involved in the evolution of Arf to improve the macrocyclization efficiency [101]. 
Moreover, we found that the gene encoding putative ArfA/B/C exists  in  the genome sequence of 
Pseudomonas fluorescens Pf0-1 (YP_347943/YP_347944/YP_347945) [102]. Arf represents a novel 
NRPS architecture that features tandem Te-domains and dual C/E domains. Interestingly, another type 
of  NRPS  involved  in  biosynthesis  of  a  siderophore,  pyoverdine,  was  also  identified  in 
arthrofactin-producing Pseudomonas sp. MIS38. A gene encoding NRPS for the chromophore part of 
pyoverdine contains a conventional E-domain [102]. This observation suggests that different NRPS 
systems with dual C/E domains and a conventional E-domain are both functional in Pseudomonas spp. 
Figure 2. The arthrofactin biosynthesis assembly line. 
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2.2.4. Viscosin and Massetolide Synthetases 
Viscosin  and  massetolide  are  structurally  related  lipononapeptides  produced  by  P.  fluorescens 
SBW25 and P. fluorescens SS101, respectively [46,48]. Viscosin has significant surfactant activity by 
reducing  surface  tension  of  water  to  28  mN/m  with  a  CMC  of  10–15  mg/L  and  forms  stable 
emulsions [46,103]. It also inhibits migration of a metastatic prostate cancer cell line without visible 
toxicity [103]. In addition, viscosin and massetolide are required for biofilm formation and swarming 
motility of Pseudomonas cells [46,48]. Viscosin/massetolide is synthesized by NRPS systems that are 
encoded by three large ORFs, termed viscA/massA, viscB/massB, and viscC/massC. The viscA/massA 
gene is not clustered with the latter genes, but is located at a different locus of the Pseudomonas 
genome. The distance between viscA/massA and the latter genes is more than 1.5 MB. Analysis of the 
amino acid sequences revealed two modules in ViscA/MassA, four modules in ViscB/MassB, and 
three  modules  in  ViscC/MassC.  Each  module  bears  A-,  T-,  and  C-domains  like  other  NRPSs. 
However, none of the five  D-amino acid-incorporating modules possesses a cognate E-domain, but 
contains  a  C/E  domain  similar  to  Arf.  Tandem  Te-domains  were  also  identified  in  the  last 
ViscC/MassC module and are likely to be functional for the biosynthesis of both lipopeptides as was 
shown  for  the  two  Te-domains  in  Arf [101].  Similar  to  other  NRPSs  involved  in  lipopeptide 
biosynthesis, the N-terminal C-domain in the first module is highly similar to the N-acyl domain and is 
presumably involved in N-acylation of the first amino acid. 
2.2.5. Orfamide Synthetase 
Orfamide  and  its  biosynthetic  genes  (ofaA/B/C)  were  discovered  from  the  P.  fluorescens  Pf-5 
genome using a genome isotope approach that employs a combination of genome sequence analysis 
and  isotope-guided  fractionation  to  identify  the  corresponding  compounds [66].  Orfamide  is  a 
lipodecapeptide consisting of a β-hydroxy fatty acid linked to a 10-amino acid cyclic peptide in which 
five amino acids are in the D-form. Orfamide is essential for swarming activity and exhibits strong 
zoosporicidal activity, but it is not involved in biofilm formation [66]. Although orfamide is composed 
of 10 amino acids, its structure is most similar to the lipononapeptide viscosin, suggesting a common 
evolutionary lineage. It is also interesting that the gene structure, ofaABC, is rather similar to arfABC 
(Figure 1). Structural analysis of OfaA/B/C identified ten modules. The first NRPS, OfaA, consists of 
two modules with an N-acyl domain at its N-terminus. Four modules were identified in the second 
NRPS, OfaB, and the last NRPS, OfaC. Similar to other Pseudomonas NRPSs, no cognate E-domains 
are found in Ofa modules. Although five amino acid residues in orfamide are in the D-form, Ofa seems 
to contain a total of six dual C/E domains. This inconsistency suggests that the NRPS system is more 
complex than previously thought. Tandem Te-domains were found in the C-terminus of OfaC, similar 
to several NRPSs from other Pseudomonas species. 
2.2.6. Putisolvin Synthetase 
Putisolvin  is  a  LPBS  synthesized  by  P.  putida  PL1445,  which  was  isolated  from  soil  heavily 
contaminated  with  polycyclic  aromatic  hydrocarbons.  Putisolvin  is  a  cyclic  lipododecapeptide 
consisting of a 12-amino acid peptide linked to a hexanoic lipid by an ester linkage between the ninth Int. J. Mol. Sci. 2011, 12                       
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serine residue and the C-terminal carboxyl group [58]. Putisolvin inhibits biofilm formation of other 
bacteria and exhibits zoosporicidal and antifungal activities [58,104]. Three genes (psoA, psoB, and 
psoC) were identified and shown to encode NRPS involved in putisolvin biosynthesis [105]. PsoA, 
PsoB, and PsoC contain two, seven, and three functional modules, respectively. The C-terminus in 
PsoC carries putative tandem Te-domains. Both domains harbor a highly conserved signature sequence 
(GXSXG) and the catalytic triad residues of Te-domains. Nine of the 12 amino acids are in the D-form, 
but  no  conventional  E-domains  were  identified [105].  Analysis  of  specific  sequence  motifs  in  the 
T-domains suggested that the first nine T-domains in Pso synthetase are responsible for transferring 
D-amino acids [98]. Amino acid sequence analysis of the C-domains indicated that dual C/E domains 
are organized downstream of the first nine modules. Prediction of A-domain substrate specificity in the 
eleventh  module  indicates  its  preference  for  Val  over  Leu  or  Ile,  which  correlates  well  with  the 
production ratios of putisolvin I and II [105].  
2.2.7. Syringafactin Synthetase 
Syringafactin is  a novel  linear lipooctapeptide produced by  P. syringae pv. tomato DC3000. It 
contains an eight-amino acid linear peptide linked to a β-hydroxy fatty acid. The Val4 residue can be 
substituted with Leu or Ile. Syringafactin shows surfactant activity and is essential for the swarming 
motility of the producing strain, but its contribution to the pathogenicity has not been tested [68]. 
Syringafactin  biosynthetic genes  were identified from  mining the  P. syringae pv.  tomato DC3000 
genome. The gene clusters syfA and syfB encode three and five NRPS modules, respectively. The 
N-acyl domain present in the initiating module of SyfA indicated that syringafactin would contain an 
N-terminal  fatty  acid  chain.  SyfB  contains  tandem  Te-domains  at  the  C-terminus.  The  
D/L-configuration of each residue has not been determined. However, based on the location of the dual 
C/E  domains  that  are  typically  located  downstream  of  D-amino  acid–incorporating  modules,  the 
structure  of  syringafactin should be fatty acyl-D-Leu1-D-Leu2-D-Gln3-Leu4-D-Thr5-Val6-D-Leu7-Leu8, 
which differs from a previous report [68]. The N-terminal C-domain of SyfA shows the highest level of 
amino acid sequence similarity with the N-terminal C-domain of ArfA. It seems likely that protein 
domains corresponding to the first three modules of the arthrofactin NRPS are absent in syringafactin 
NRPS.  This  observation  suggests  that  the  syringafactin  NRPS  system  in  P.  syringae  pv.  tomato 
DC3000 evolved from the arthrofactin system, after which three modules of the arthrofactin NRPS 
were deleted, resulting in the fusion of the N-terminus of ArfA with a portion of ArfB. Importantly, the 
deleted modules include the module that incorporates the threonyl residue that forms the ester linkage 
involved  in  cyclization  of  arthrofactin.  Indeed,  the  structure  of  syringafactin  is  reported  to  be  a 
linear form.  
2.2.8. Entolysin Synthetase 
Entolysin  is  a  cyclic  lipotetradecapeptide  produced  by  an  entomopathogenic  bacterium 
Pseudomonas entomophila. This bacterium is able to infect and effectively kill various insects, and it is 
closely related to  the saprophytic soil bacterium  P. putida. Entolysin has a relatively small cyclic 
peptide moiety in which a lactone ring is formed between the tenth and the last amino acid. Entolysin 
is required for swarming motility and exhibits hemolytic and surfactant activity as described for other Int. J. Mol. Sci. 2011, 12                       
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lipopeptides,  but  it  does  not  participate  in  the  virulence  of  the  producing  strain  for  killing 
Drosophila  [65]. Three genes encoding entolysin synthetases were identified (etlA, etlB, and etlC). 
The deduced amino acid sequences are similar to other NRPSs and closely related to Pso synthetase in 
P. putida PCL1445. The etlA gene is not physically linked with etlB and etlC in the P. entomophila 
genome. This organization has also been reported for the viscosin and massetolide gene clusters. EtlA, 
EtlB, and EtlC comprise two, eight, and four functional modules of NRPS, all of which correspond to 
the number of amino acid residues in the product peptide. These modules are composed of typical 
domains. However, no cognate E-domains have been identified in EtlA/B/C. Amino acid sequence 
analysis indicated that all of the C-domains but C12 and C13 could function as dual C/E domains. In 
addition, the first C-domain of EtlA is similar to the N-acyl domain of other lipopeptides, and tandem 
Te-domains were identified in the C-terminus of EtlC [65].  
3. Gene Regulation in Bacillus 
Gene regulation of LPBSs produced by Bacillus spp. has been most intensively investigated within 
the  surfactin  biosynthesis  system  (Figure  3).  Expression  of  the  gene  srfA  is  controlled by several 
peptide pheromones including ComX and Phr [106]. B. subtilis encodes eight Phr peptides (PhrA, 
PhrC [CSF], PhrE, PhrF, PhrG, PhrH, PhrI, and PhrK) and 11 aspartyl-phosphate phosphatase proteins 
(RapA to RapK). Each Phr peptide inhibits the activity of cotranscribed Rap protein. RapC, RapF, and 
RapK act as negative regulators of srfA  [107]. ComX interacts with the membrane-bound histidine 
kinase ComP, which autophosphorylates upon stimulation and then transfers its phosphate to a serine 
residue  in  the  response  regulator  ComA.  The  phosphorylated  ComA  binds  to  ComA  boxes 
(T/GCGG-N4-CCGCA)  upstream  of  the  srfA  promoter  as  a  tetramer  and  initiates  transcription  of 
srfA [108,109]. Recently, it was found that ComA binds to a degenerate tripartite sequence consisting 
of three recognition elements (RE). RE1 and RE2 contain the inverted repeats previously characterized 
as part of the ComA-boxes. Meanwhile, RE3 is located downstream of RE1 and RE2 with a consensus 
sequence identical to that of RE1 [110]. In addition, mutation at three non-aspartate amino acids in the 
N-terminal portion of ComA decreases surfactin production [111]. These three amino acids may be 
involved in the phosphorylation mechanism. It was previously reported that glucose can stimulate the 
transcription of comA and consequently increases the expression of srfA [112,113]. Induction of srfA 
requires the oligopeptide permease Spo0K, which is involved in PhrC import [114]. On the other hand, 
expression of srfA is downregulated upon treatment with H2O2; this evidence led to identification of 
the H2O2 stress responsive regulator PerR. PerR positively regulates srfA expression by binding to 
PerR boxes located in the upstream region of ComA boxes in which H2O2 inhibits the DNA-binding 
activity of PerR  [115]. Furthermore, the chaperon subunit ClpX and protease ClpP are required for the 
transcription of srfA at a step that follows ComP-dependent activation of ComA [116]. An additional 
transcription factor DegU also functions as a positive regulator for srfA transcription [117]. Int. J. Mol. Sci. 2011, 12                       
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Figure 3. The model of gene regulation involved in surfactin biosynthesis. Closed-head 
arrows indicate positive regulation whereas closed circles indicate negative regulation.  
 
 
Overexpression of RapD, RapG, and RapH inhibits srfA transcription, and production of these Rap 
proteins is suppressed by RghR [118,119]. Mutation in sodA, which encodes superoxide dismutase, 
inhibits transcription of the comQXP quorum-sensing locus, thereby preventing srfA expression [120]. 
At high concentrations of amino acids such as Ile, Leu, and Val, CodY represses transcription of srfA 
by interacting specifically with the srfA promoter [121]. Like CodY, AbrB also negatively regulates 
srfA  transcription.  Expression  of  srfA  is  also  repressed  by  the  RNA  polymerase-binding  protein  
Spx [122].  On  the  other  hand,  the  Spx-RNA  polymerase  interaction  is  required  for  positive 
transcriptional  control  of  genes  in  response  to  thiol-oxidative  stress [123].  Furthermore,  
4'-phosphopantetheinyl  transferase (Sfp/PPTase) is  required for the activation of SrfA enzymes by 
converting the inactive apo-forms of the T-domains to the active holo-forms [124]. An acyltransferase 
SrfA-Te is also required in the initial step of transferring a hydroxyl fatty acid to the first amino acid in 
the peptide. The surfactin self-resistance protein, YerP, is required for surfactin exportation [125]. 
Regulation  of  the  fengycin/plipastatin  genes  is  positively  controlled  by  DegQ,  an  enhancer  of 
extracellular  protease  production [126].  degQ  is  a  pleiotropic  regulatory  gene  that  controls  the 
production of several hydrolytic enzymes [127]. Production of plipastatin is severely reduced in the 
degQ mutant, but no significant change is observed in surfactin production. A Sfp-like protein, Lpa-8, 
is  also  required  for  plipastatin  production  in  B.  subtilis  YB8 [128].  Overexpression  of  degQ  in 
B. subtilis 168 expressing lpa-8 yields a 10-fold increase in plipastatin production [126]. Recently, 
transcription analysis of fen in B. subtilis F29-3 demonstrated that RNA polymerase binds to the A- 
and T-rich sequences, called the UP element, which is located upstream of the fen promoter [129]. Int. J. Mol. Sci. 2011, 12                       
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Gene  regulation  of  the  iturin  family  was  first  demonstrated  within  mycosubtilin-producing 
B. subtilis ATCC6633. Expression of the myc operon is independent of ComA, but still seems to be 
regulated via quorum sensing, as PhrC strongly stimulates expression. The sigma H factor, Spo0H, 
also influences expression of the myc operon, and addition of PhrC to the culture medium compensates 
for loss of Spo0H expression. Finally, the transition state regulator AbrB represses expression of myc, 
as deletion of abrB results in increased myc expression [130]. Further information regarding the gene 
regulation was obtained from the study of the bmy operon produced using the B. amyloliquefaciens 
FZB42.  Expression  of  bmy  is  dependent  on  a  single  sigma  A  factor-dependent  promoter  and  is 
positively controlled by the small regulatory protein DegQ, similar to fen. Similar to srfA, the global 
regulators DegU and ComA are required for the full transcriptional activation of bmy. DegU plays a 
key  role  because  it  binds  directly  to  two  sites  located  upstream  of  the  bmy  promoter.  Moreover, 
post-transcriptional  regulation  of  bacillomycin  production  is  also  suggested  for  both  DegU  and  a 
transmembrane  protein,  YczE [131].  Like  other  lipopeptide  synthetases  in  Bacillus,  the  Sfp-like 
protein,  Lpa-14,  is  also  required  for  iturin  production [132].  Mutation  of  the  Sfp-encoding  gene 
simultaneously  prevents  B.  amyloliquefaciens  FZB42  from  producing  bacillomycin,  fengycin, 
and surfactin [131].  
4. Gene Regulation in Pseudomonas 
Similar to ComP/ComA in Bacillus, a two-component system has been identified as the master 
transcriptional regulation system in Pseudomonads (Figure 4). Typically, this system consists of  a 
sensor kinase GacS and response regulator GacA. GacS was first described in P. syringae pv. syringae 
B728a as an essential factor for lesion manifestation. Meanwhile, GacA was first identified as a global 
activator of antibiotic and cyanide production in P. fluorescens CHA0 [133]. It is proposed that upon 
interaction  with  the  signal(s),  GacS  is  activated  by  autophosphorylation  and  then  GacA  acts  as  a 
phosphoryl acceptor. After trans-phosphorylation, GacA activates transcription of the regulatory gene, 
which in turn controls the expression of target genes [133]. Based on bacterial two-hybrid analysis, the 
entire GacA molecule is necessary for GacA interaction with itself or GacS [134]. The GacS/GacA 
system  positively  controls  the  expression  of  genes  required  for  the  synthesis  of  lipopeptides 
(syringomycin,  amphisin,  putisolvin,  and  entolysin)  because  mutation  in  either  gene  impairs 
lipopeptide  production [65,135–138].  A  quorum-sensing  system  that  triggers  GacA/GacS 
phosphorylation  during  high  cell  density  is  essential  for  biosynthesis  of  the  lipopeptide 
putisolvin [139].  In  Gram-negative  bacteria,  the  quorum-sensing  system  largely  relies  on  the 
interaction of signaling molecule N-acyl homoserine lactones (AHLs) that are synthesized via LuxI 
protein with the transcriptional regulator LuxR. The quorum-sensing system in P. putida PCL1445 is 
composed of LuxI-homologous PpuI, LuxR-homologous PpuR, and RsaL. Expression of the genes 
ppuI  and  ppuR  are  required  for  the  biosynthesis  of  AHLs,  and  mutation  of  these  genes  reduces 
putisolvin production. Meanwhile, overproduction of AHLs and putisolvin is observed in the rsaL 
mutant.  This  observation  suggests  that  RsaL  acts  as  a  repressor  of  PpuI  and  PpuR.  In  contrast, 
biosynthesis  of  the  lipopeptides  massetolide,  amphisin,  and  syringomycin  is  not  regulated  by 
AHL-based quorum sensing [48]. Downstream of the Gac system, the cognate transcriptional regulator 
LuxR regulates the production of several lipopeptides that bind to the operator of the NRPS genes. Int. J. Mol. Sci. 2011, 12                       
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LuxR protein contains a DNA-binding helix-turn-helix motif in its C-terminal region. In Pseudomonas 
sp.  MIS38,  the  LuxR-type  transcription  factor,  ArfF,  positively  controls  transcription  of  the  gene 
arf [140].  LuxR-type  protein  is  also  implicated  in  the  biosynthesis  of  entolysin,  putisolvin,  and 
syringafactin, and mutation of this gene results in the loss of lipopeptide production [65,68,105,141]. 
Two types of LuxR-type proteins are involved in biosynthesis of syringomycin, syringopeptin, and 
viscosin. SalA and SyrF are the LuxR-type proteins responsible for the production of two lipopeptides, 
syringomycin and syringopeptin, in  P. syringae pv. syringae B301D. SalA is suggested to control 
transcription  of SyrF, an apparent homolog of ArfF,  and SyrF binds and trans-activates the target 
NRPS promoter [142]. Mutation of two LuxR-type proteins in P. fluorescens SBW25, ViscAR and 
ViscBCR, results in the reduction of NRPS gene transcription and loss of viscosin production [143]. 
Recently, heat shock proteins were shown to regulate biosynthesis of putisolvin and arthrofactin [140,141]. 
Mutation in the gene encoding DnaK, a HSP70 class heat shock protein, impairs putisolvin production 
in P. putida PCL1445. Together with DnaJ, DnaK regulates putisolvin synthesis at low temperature. 
Elimination of arthrofactin synthesis was identified following mutation of the gene encoding HtpG, a 
HSP90 class heat shock protein. However, normal expression of the arthrofactin synthetase genes is 
retained in the HtpG mutant. Thus, HtpG appears to be involved in the proper folding of positive 
transcription factors or in the assembly of the NRPS complex. The serine protease ClpP regulates 
massetolide biosynthesis in P. fluorescens SS101 via LuxR transcriptional regulators, and expression 
of ClpP is independent of regulation by the GacS/GacA system [144]. In contrast to surfactin synthesis, 
the chaperon subunit ClpX is not involved in the production of massetolide, and its gene is transcribed 
independently of clpP. Random mutagenesis in Pseudomonas MIS38 also led to identification of SpoT 
as  a  new  regulator  of  arthrofactin  synthesis [140].  Mutation  in  the  SpoT-encoding  gene  prevents 
MIS38 from producing arthrofactin. SpoT is a (p)ppGpp synthetase/hydrolase responsible for cellular 
metabolism  during  nutritional  starvation [145].  Epistasis  analysis  revealed  that  spoT  positively 
regulates arthrofactin biosynthesis through arfF and arfB. Post-translational modification of NRPS in 
pseudomonads is also catalyzed by PPTase [146–148]. 
Exportation  of  lipopeptide  in  pseudomonads  requires  ATP-binding  cassette  (ABC)  transporter 
systems,  and  the  ABC  transporter  genes  are  then  clustered  together  with  a  synthetase 
gene [48,65,68,98,105].  Exportation  of  syringomycin  and  syringopeptin  requires  two  transporter 
systems known as SyrD and PseABC. SyrD is proposed to function as an ATP-driven efflux pump. 
Only  trace  quantities  of  both  lipopeptides  are  produced  by  the  syrD  mutant,  and  the  cells  show 
significantly lower virulence [149, 150]. On the other hand, the tripartite ABC-type efflux transporter 
PseABC is homologous to the resistance-nodulation-cell division, RND, efflux system. Mutation in 
each of the genes pseABC results in a 40 to 60% decrease in both syringomycin and syringopeptin 
production [151]. The transporter system for arthrofactin was recently characterized in Pseudomonas 
MIS38 [152].  The  genes  encoding  a  putative  periplasmic  protein  (ArfD)  and  a  putative  ABC 
transporter  (ArfE)  are  located  downstream  of  the  arf  gene  cluster.  Arthrofactin  production  is 
temporarily reduced in both mutants, but it eventually reached a similar level to that of MIS38 after 
12 h  cultivation.  Furthermore,  exportation  of  arthrofactin  is  almost  completely  blocked  by  ABC 
transporter inhibitors. This suggests that multiple ABC transporter systems can export arthrofactin and 
that accumulation of arthrofactin is toxic to the cells. Two genes that are predicted to encode homologs Int. J. Mol. Sci. 2011, 12                       
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of the ABC transporters MacA and MacB in E. coli are located downstream of the putisolvin and 
entolysin synthetase genes [153]. Analysis of macA and macB mutations in P. putida PCL1445 shows 
a  70%  decrease  in  putisolvin  production [105].  Meanwhile,  macA  and  macB  mutations  in 
P. entomophila  result  in  almost  a  complete  loss  of  entolysin  production [65].  Therefore,  we 
hypothesize that multiple ABC transporter systems generally play a role in transportation of LPBSs 
in pseudomonads. 
Figure  4.  The  model  of  gene  regulation  involved  in  lipopeptide  biosynthesis  by 
Pseudomonas.  Closed-head  arrows  indicate  positive  regulation  whereas  closed  circles 
indicate negative regulation. 
 
 
5. Genetic Engineering of NRPS to Create Novel Products 
A large number of LPBSs are synthesized by NRPSs that share similar modular architecture of their 
repetitive catalytic units and a similar assembly-line mechanism. However, recent genome analysis of 
the  lipopeptide  synthetases  from  both  Bacillus  and  Pseudomonas  strains  revealed  novel  NRPS 
architecture  that  does  not  completely  conform  to  the  co-linearity  rule,  which  encompasses 
multifunctional hybrid enzymes that can directly incorporate D-amino acid residues. In addition, most 
of the recently identified lipopeptide synthetases in Pseudomonas spp lack the cognate E-domains, but 
contain a dual C/E domain and also feature tandem Te-domains. These variations demonstrate natural 
versatility  in  evolving  complex  pathways  for lipopeptide biosynthesis  and may  allow for artificial 
alteration of the protein template with the aim of reprogramming it to create novel compounds with 
improved properties.  Int. J. Mol. Sci. 2011, 12                       
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Recently, new strategies for engineering NRPSs have been developed. The first successful report 
examined exchanging or replacing the minimal module (A- and T-domains) with the last Leu7 module 
within SrfA-C, a single-module with the simplest structure [14]. This module was deleted and replaced 
with  several bacterial and fungal A/T-domains by homologous recombination. Construction of the 
gene  encoding  hybrid  SrfA  leads  to  the  production  of  surfactin  variants  that  retain  their  activity 
(Table 3).  Using  the  same  strategy,  A/T-domain  exchange  was  applied  to  multi-modular  SrfA. 
Swapping of the Leu2 module results in an altered product whose peptide chain is shorter than that of 
wild-type [154]. However, this minimal module replacement resulted in a very low yield of variants. 
Therefore, Yakimov and coworkers (2000) developed a whole-module replacement within SrfA. A 
complete set of C/A/T-domains of the lichenysin A synthetase Gln1 module was introduced into the 
Glu1 module of SrfA. An altered product, surfactin [Gln1], was produced by the recombinant B. subtilis 
at  a  level  similar  to  that  of  wild-type  surfactin  and  it  also  exhibits  stronger  surface  activity  than 
surfactin [155]. The SrfA could also be modified by translocation of the C-terminal Te-domain to the 
end of the internal domains, thus resulting in new linear surfactin analogs [156]. Furthermore, the use 
of recombinant Te-domain to catalyze regiospecific cyclization of synthetic peptides or lipopeptides 
in vitro  is  a  powerful  approach  for  generating  libraries  of  novel  compounds  with  improved 
properties [157,158]. Another powerful approach for the genetic manipulation of NRPS templates is 
the  directed  mutation  of  the  substrate  specificity  within  the  A-domain  based  on  its 
specificity-conferring code [159]. Specificity-conferring codes of the Asp5 module within SrfA were 
adapted for the recognition of Asn. The engineered B. subtilis produces the new lipoheptapeptide, 
surfactin [Asn5] [13]. Along the same line, directed mutation of the Asp7 A-domain to Asn7 within 
CDA synthetase from Streptomyces coelicolar leads to production of the expected lipoundecapeptide 
containing Asn7 and an unexpected linear lipohexapeptide intermediate [160]. A reduction or increase 
in  the  number  of  peptide  residues  is  an  alternate  approach  to  generate  structural  diversity  of 
lipopeptides and glycopeptides. Deletion of an entire Leu2 module in SrfA causes secretion of the 
predicted  surfactin  variant  with  a  smaller  cyclic  peptide.  Furthermore,  a  novel  lipohexapeptide  is 
produced with a significantly high yield and enhanced antimicrobial activities [161, 162]. Amino acid 
insertion by module extension has been performed within the vancomycin-type glycopeptide antibiotic, 
balhimycin. Insertion of an entire D-hydroxyphenylglycine module into the balhimycin assembly line 
between modules 4 and 5 results in an elongated octapeptide product [163]. C-terminally truncated 
hexa- to di-peptide metabolites are also detected. An alternative approach was examined based on the 
function  of  communication-mediating  (COM)  domains  that  play  an  important  role  in  the 
intermolecular communication within the NRPS system [164]. Swapping of COM domains have been 
exploited within SrfA and allow for biosynthesis of surfactin variants with different peptide chain 
lengths [165].  Using  plasmid  and  transposon  mutation  of  the  srfA  operon  at  specific  and  random 
positions, various intermediates from lipodipeptides to lipohexapeptides were identified by whole-cell 
MALDI-TOF  MS  analysis [166].  Although  several  NRPSs  involved  in  lipopeptide  production  in 
pseudomonads  have  also  been  characterized,  there  is  limited  information  available  for  rational 
modification  of  their  NRPS  modules  in  vivo.  Utilizing  a  complementation  method,  Ackerley  and 
Lamont  (2004)  examined  the  possibility  for  engineering  pyoverdine  synthetase  (PvdD)  in 
P. aeruginosa  PAO1  to  generate  novel  pyoverdine  analogs.  Introduction  of  the  Thr-incorporating Int. J. Mol. Sci. 2011, 12                       
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module from other species into the pvdD mutant restores pyoverdine production [167]. Recently, the 
researchers at Cubist Pharmaceuticals, Inc. have shown how these approaches can also be used for the 
production of lipopeptide variants by Streptomyces spp. with improved antibiotic activities [168,169]. 
Table 3. Primary structure of engineered LPBSs produced by B. subtilis. 
Name  Structure  Ref. 
Cyclic products     
Surfactin[Val7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Val   [14] 
Surfactin[Phe7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Phe   [14] 
Surfactin[Orn7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Orn   [14] 
Surfactin[Cys7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Cys   [14] 
Surfactin[Gln1]  FA-β-OH-L-Gln-L-Leu-D-Leu-L-Val-L-Asp-D-Leu-L-Leu   [155] 
Surfactin[Asn5]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asn-D-Leu-L-Leu   [13] 
Surfactin[Orn2]  FA-β-OH-L-Glu-L-Orn-D-Leu-L-Val-L-Asp-D-Leu-L-Leu   [154] 
Surfactin[Orn2∆Leu3/Val4]  FA-β-OH-L-Glu-L-Orn-L-Asp-D-Leu-L-Leu   [154] 
Surfactin[Orn2∆Leu6/7]  FA-β-OH-L-Glu-L-Orn-D-Leu-L-Val-L-Asp   [154] 
Surfactin[∆Leu2]  FA-β-OH-L-Glu-D-Leu-L-Val-L-Asp-D-Leu-L-Leu   [161,162] 
Linear products     
Surfactin[∆Leu7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-D-Leu   [14] 
Surfactin[∆Leu6/7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val-L-Asp   [156] 
Surfactin[∆Asp5Leu6/7]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Val   [156] 
Surfactin[∆Val4Asp5Leu6]  FA-β-OH-L-Glu-L-Leu-D-Leu-L-Leu   [165] 
6. Conclusion 
Gram-positive Bacillus and Gram-negative Pseudomonas strains produce a variety of lipopeptides 
with  remarkable  surface  and  biological  activities.  In  contrast  to  the  structural  diversity  of  these 
lipopeptides,  their  biosynthetic  mechanism  is  basically  conserved.  They  are  synthesized 
nonribosomally by a mega-peptide synthetase unit, NRPS, which is composed of several cooperating 
multifunctional modules, each capable of performing one cycle of peptide elongation. To become an 
active form, they are post-translationally modified by a PPTase and properly assembled by DnaJ/K and 
HtpG proteins. However, recent analysis of the lipopeptide synthetases suggests that there are several 
variants of NRPS architecture. Modification of NRPS by genetic engineering of the encoding genes is 
a promising method to produce useful variants. Accumulation of genetic information for lipopeptide 
synthetases  should  contribute  to  design  biosurfactants  with  higher  surface  activity  and/or  novel 
features. Moreover, understanding of their biosynthetic pathways and genetic regulation mechanisms 
will facilitate not only uncovering the evolution of nonribosomal peptide synthesis mechanisms, but 
also the development of cost-effective methods for large-scale production of useful lipopeptides. 
Acknowledgements 
N.R. acknowledges BIOTEC, NSTDA for providing a General Research fund (BT-B-02-LM-BA-
5204). Experimental works on arthrofactin in M.M. laboratory was supported by The Takeda Science 
Foundation and KAKENHI (17510171). Int. J. Mol. Sci. 2011, 12                       
 
 
161 
References 
1.  Georgiou,  G.;  Lin,  S.C.;  Sharma,  M.M.  Surface-active  compounds  from  microorganisms. 
Biotechnology (NY) 1992, 10, 60–65. 
2.  Desai,  J.D.;  Banat,  I.M.  Microbial  production  of  surfactants  and  their  commercial  potential. 
Microbiol. Mol. Biol. Rev. 1997, 61, 47–64. 
3.  Arima, K.; Kakinuma, A.; Tamura, G. Surfactin, a crystalline peptidelipid surfactant produced by 
Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem. 
Biophys. Res. Commun. 1968, 31, 488–494. 
4.  Nishikiori,  T.;  Naganawa,  H.;  Muraoka,  Y.;  Aoyagi,  T.;  Umezawa,  H.  Plipastatins:  new 
inhibitors  of  phospholipase  A2,  produced  by  Bacillus  cereus  BMG302-fF67.  III.  Structural 
elucidation of plipastatins. J. Antibiot. (Tokyo) 1986, 39, 755–761. 
5.  Peypoux, F.; Pommier, M.T.; Das, B.C.; Besson, F.; Delcambe, L.; Michel, G. Structures of 
bacillomycin D and bacillomycin L peptidolipid antibiotics from Bacillus subtilis. J. Antibiot. 
(Tokyo) 1984, 37, 1600–1604. 
6.  Grangemard, I.; Bonmatin, J.M.; Bernillon, J.; Das, B.C.; Peypoux, F. Lichenysins G, a novel 
family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation 
and structural evaluation by NMR and mass spectrometry. J. Antibiot. (Tokyo) 1999, 52, 363–373. 
7.  Yakimov,  M.M.;  Abraham,  W.R.;  Meyer,  H.;  Laura,  G.;  Golyshin,  P.N.  Structural 
characterization  of  lichenysin  A  components  by  fast  atom  bombardment  tandem  mass 
spectrometry. Biochim. Biophys. Acta 1999, 1438, 273–280. 
8.  Morikawa,  M.;  Hirata,  Y.;  Imanaka,  T.  A  study  on  the  structure-function  relationship  of 
lipopeptide biosurfactants. Biochim. Biophys. Acta 2000, 1488, 211–218. 
9.  Nielsen, T.H.; Sorensen, D.; Tobiasen, C.;  Andersen, J.B.; Christophersen, C.; Givskov, M.; 
Sorensen,  J.  Antibiotic  and  biosurfactant  properties  of  cyclic  lipopeptides  produced  by 
fluorescent Pseudomonas spp. from the sugar beet rhizosphere. Appl. Environ. Microbiol. 2002, 
68, 3416–3423. 
10.  Sorensen,  D.;  Nielsen,  T.H.;  Christophersen,  C.;  Sorensen,  J.;  Gajhede,  M.  Cyclic 
lipoundecapeptide amphisin from Pseudomonas sp. strain DSS73. Acta Crystallogr. C 2001, 57, 
1123–1124. 
11.  Sorensen, D.; Nielsen, T.H.; Sorensen, J.; Christophersen, C. Cyclic lipoundecapeptide lokisin 
from Pseudomonas sp. strain DSS41. Tetrahedron Lett. 2002, 43, 4421–4423. 
12.  Ui, H.; Miyake, T.; Iinuma, H.; Imoto, M.; Naganawa, H.; Hattori, S.; Hamada, M.; Takeuchi, T.; 
Umezawa, S.; Umezawa, K. Pholipeptin, a novel cyclic lipoundecapeptide from Pseudomonas 
fluorescens. J. Org. Chem. 1997, 62, 103–108. 
13.  Eppelmann, K.; Stachelhaus, T.; Marahiel, M.A. Exploitation of the selectivity-conferring code 
of  nonribosomal  peptide  synthetases  for  the  rational  design  of  novel  peptide  antibiotics. 
Biochemistry 2002, 41, 9718–9726. 
14.  Stachelhaus, T.; Schneider, A.; Marahiel, M.A. Rational design of peptide antibiotics by targeted 
replacement of bacterial and fungal domains. Science 1995, 269, 69–72. 
15.  Koglin, A.; Walsh, C.T. Structural insights into nonribosomal peptide enzymatic assembly lines. 
Nat. Prod. Rep. 2009, 26, 987–1000. Int. J. Mol. Sci. 2011, 12                       
 
 
162 
16.  Raaijmakers, J.M.; de Bruijn, I.; Nybroe, O.; Ongena, M. Natural functions of lipopeptides from 
Bacillus and Pseudomonas: more than surfactants and antibiotics. FEMS Microbiol. Rev. 2010, 
DOI: 10.1111/j.1574-6976.2010.00221.x. 
17.  Roongsawang, N.; Thaniyavarn, J.; Thaniyavarn, S.; Kameyama, T.; Haruki, M.; Imanaka, T.; 
Morikawa,  M.;  Kanaya,  S.  Isolation  and  characterization  of  a  halotolerant  Bacillus  subtilis  
BBK-1 which produces three kinds of lipopeptides: bacillomycin L, plipastatin, and surfactin. 
Extremophiles 2002, 6, 499–506. 
18.  Koumoutsi,  A.;  Chen,  X.H.;  Henne,  A.;  Liesegang,  H.;  Hitzeroth,  G.;  Franke,  P.;  Vater,  J.; 
Borriss,  R. Structural and functional characterization of gene clusters directing nonribosomal 
synthesis  of  bioactive  cyclic  lipopeptides  in  Bacillus  amyloliquefaciens  strain  FZB42.  
J. Bacteriol. 2004, 186, 1084–1096. 
19.  Romero,  D.;  de  Vicente,  A.;  Rakotoaly,  R.H.;  Dufour,  S.E.;  Veening,  J.W.;  Arrebola,  E.; 
Cazorla, F.M.; Kuipers, O.P.; Paquot, M.; Perez-Garcia, A. The iturin and fengycin families of 
lipopeptides  are  key  factors  in  antagonism  of  Bacillus  subtilis  toward  Podosphaera  fusca.  
Mol. Plant Microbe Interact. 2007, 20, 430–440. 
20.  Kim,  P.I.;  Ryu,  J.;  Kim,  Y.H.;  Chi,  Y.T.  Production  of  biosurfactant  lipopeptides  iturin  A, 
fengycin  and  surfactin  A  from  Bacillus  subtilis  CMB32  for  control  of  Colletotrichum 
gloeosporioides. J. Microbiol. Biotechnol. 2010, 20, 138–145. 
21.  Yakimov,  M.M.;  Timmis,  K.N.;  Wray,  V.;  Fredrickson,  H.L.  Characterization  of  a  new 
lipopeptide  surfactant  produced  by  thermotolerant  and  halotolerant  subsurface  Bacillus 
licheniformis BAS50. Appl. Environ. Microbiol. 1995, 61, 1706–1713. 
22.  Bonmatin,  J.M.;  Laprevote,  O.;  Peypoux,  F.  Diversity  among  microbial  cyclic  lipopeptides: 
iturins  and  surfactins.  Activity-structure  relationships  to  design  new  bioactive  agents.  Comb. 
Chem. High Throughput Screen 2003, 6, 541–556. 
23.  Grangemard, I.; Wallach, J.; Maget-Dana, R.; Peypoux, F. Lichenysin: a more efficient cation 
chelator than surfactin. Appl. Biochem. Biotechnol. 2001, 90, 199–210. 
24.  Rodrigues,  L.;  Banat,  I.M.; Teixeira, J.;  Oliveira, R. Biosurfactants: potential applications in 
medicine. J. Antimicrob. Chemother. 2006, 57, 609–618. 
25.  Bais, H.P.; Fall, R.; Vivanco, J.M. Biocontrol of Bacillus subtilis against infection of Arabidopsis 
roots  by  Pseudomonas  syringae  is  facilitated  by  biofilm  formation  and  surfactin  production. 
Plant Physiol. 2004, 134, 307–319. 
26.  Hofemeister, J.; Conrad, B.; Adler, B.; Hofemeister, B.; Feesche, J.; Kucheryava, N.; Steinborn, 
G.;  Franke,  P.;  Grammel,  N.;  Zwintscher,  A.;  Leenders,  F.;  Hitzeroth,  G.;  Vater,  J.  Genetic 
analysis of the biosynthesis of nonribosomal peptide and polyketide-like antibiotics, iron uptake 
and biofilm formation by Bacillus subtilis A1/3. Mol. Genet. Genomics 2004, 272, 363–378. 
27.  Kearns, D.B.; Losick, R. Swarming motility in undomesticated Bacillus subtilis. Mol. Microbiol. 
2003, 49, 581–590. 
28.  Julkowska,  D.;  Obuchowski,  M.;  Holland,  I.B.;  Seror,  S.J.  Comparative  analysis  of  the 
development of swarming communities of Bacillus subtilis 168 and a natural wild type: critical 
effects of surfactin and the composition of the medium. J. Bacteriol. 2005, 187, 65–76. Int. J. Mol. Sci. 2011, 12                       
 
 
163 
29.  Branda,  S.S.;  Gonzalez-Pastor,  J.E.;  Ben-Yehuda,  S.;  Losick,  R.;  Kolter,  R.  Fruiting  body 
formation by Bacillus subtilis. Proc. Natl. Acad. Sci. USA 2001, 98, 11621–11626. 
30.  Mireles, J.R.; Toguchi, A.; Harshey, R.M. Salmonella enterica serovar typhimurium swarming 
mutants with altered biofilm-forming abilities: surfactin inhibits biofilm formation. J. Bacteriol. 
2001, 183, 5848–5854. 
31.  Kakinuma,  A.;  Ouchida,  A.;  Shima,  T.;  Sugino,  H.;  Isono,  M.;  Tamura,  G.;  Arima,  K. 
Conformation of the structure of surfactin by mass spectrometry. Agric. Biol. Chem. 1969, 33, 
1669–1671. 
32.  Konz, D.; Doekel, S.; Marahiel, M.A. Molecular and biochemical characterization of the protein 
template controlling biosynthesis of the lipopeptide lichenysin. J. Bacteriol. 1999, 181, 133–140. 
33.  Lin,  S.C.;  Minton,  M.A.;  Sharma,  M.M.;  Georgiou,  G.  Structural  and  immunological 
characterization  of  a  biosurfactant  produced  by  Bacillus  licheniformis  JF-2.  Appl.  Environ. 
Microbiol. 1994, 60, 31–38. 
34.  Jenny,  K.;  Kappeli,  O.;  Fiechter,  A.  Biosurfactants  from  Bacillus  licheniformis:  structural 
analysis and characterization. Appl. Microbiol. Biotechnol. 1991, 36, 5–13. 
35.  Horowitz, S.; Gilbert, J.N.; Griffin, W.M. Isolation and characterization of a surfactant produced 
by Bacillus licheniformis 86. J. Indus. Microbiol. 1990, 6, 243–248. 
36.  Naruse, N.; Tenmyo, O.; Kobaru, S.; Kamei, H.; Miyaki, T.; Konishi, M.; Oki, T. Pumilacidin, a 
complex of new antiviral antibiotics. Production, isolation, chemical properties, structure and 
biological activity. J. Antibiot (Tokyo) 1990, 43, 267–280. 
37.  Volpon, L.; Besson, F.; Lancelin, J.M. NMR structure of antibiotics plipastatins A and B from 
Bacillus subtilis inhibitors of phospholipase A(2). FEBS Lett. 2000, 485, 76–80. 
38.  Isogai, I.; Takayama, S.; Murakoshi, S.; Suzuki, A. Structure of β-amino acids in antibiotics 
iturin A. Tetrahedron Lett. 1982, 23, 3065–3068. 
39.  Volpon, L.; Tsan, P.; Majer, Z.; Vass, E.; Hollosi, M.; Noguera, V.; Lancelin, J.M.; Besson, F. 
NMR structure determination of a synthetic analogue of bacillomycin Lc reveals the strategic role 
of L-Asn1 in the natural iturinic antibiotics. Spectrochim. Acta Part A 2007, 67, 1374–1381. 
40.  Duitman, E.H.; Hamoen, L.W.; Rembold, M.; Venema, G.; Seitz, H.; Saenger, W.; Bernhard, F.; 
Reinhardt,  R.;  Schmidt,  M.;  Ullrich,  C.;  Stein,  T.;  Leenders,  F.;  Vater,  J.  The  mycosubtilin 
synthetase  of  Bacillus  subtilis  ATCC6633:  a  multifunctional  hybrid  between  a  peptide 
synthetase, an amino transferase, and a fatty acid synthase. Proc. Natl. Acad. Sci. USA 1999, 96, 
13294–13299. 
41.  Batrakov, S.G.; Rodionova, T.A.; Esipov, S.E.; Polyakov, N.B.; Sheichenko, V.I.; Shekhovtsova, 
N.V.; Lukin, S.M.; Panikov, N.S.; Nikolaev, Y.A. A novel lipopeptide, an inhibitor of bacterial 
adhesion, from the thermophilic and halotolerant subsurface Bacillus licheniformis strain 603. 
Biochim. Biophys. Acta 2003, 1634, 107–115. 
42.  Lee, S.C.; Kim, S.H.; Park, I.H.; Chung, S.Y.; Choi, Y.L. Isolation and structural analysis of 
bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and 
crude oil-emulsifying activity. Arch. Microbiol. 2007, 188, 307–312. 
43.  He, H.; Shen, B.; Korshalla, J.; Carter, G.T. Circulocins, new antibacterial lipopeptides from 
Bacillus circulans, J2154. Tetrahedron 2001, 57, 1189–1195. Int. J. Mol. Sci. 2011, 12                       
 
 
164 
44.  Li, J.; Jensen, S.E. Nonribosomal biosynthesis of fusaricidins by Paenibacillus polymyxa PKB1 
involves direct activation of a D-amino acid. Chem. Biol. 2008, 15, 118–127. 
45.  Hathout,  Y.;  Ho,  Y.P.;  Ryzhov,  V.;  Demirev,  P.;  Fenselau,  C.  Kurstakins:  a  new  class  of 
lipopeptides isolated from Bacillus thuringiensis. J. Nat. Prod. 2000, 63, 1492–1496. 
46.  de  Bruijn,  I.;  de  Kock,  M.J.;  Yang,  M.;  de  Waard,  P.;  van  Beek,  T.A.;  Raaijmakers,  J.M. 
Genome-based  discovery,  structure  prediction  and  functional  analysis  of  cyclic  lipopeptide 
antibiotics in Pseudomonas species. Mol. Microbiol. 2007, 63, 417–428. 
47.  Nielsen,  T.H.;  Christophersen,  C.;  Anthoni,  U.;  Sorensen,  J.  Viscosinamide,  a  new  cyclic 
depsipeptide with  surfactant and antifungal  properties produced by  Pseudomonas fluorescens 
DR54. J. Appl. Microbiol. 1999, 87, 80–90. 
48.  de Bruijn, I.; de Kock, M.J.; de Waard, P.; van Beek, T.A.; Raaijmakers, J.M. Massetolide A 
biosynthesis in Pseudomonas fluorescens. J. Bacteriol. 2008, 190, 2777–2789. 
49.  Quail, J.W.; Ismail, N.; Pedras, M.S.; Boyetchko, S.M. Pseudophomins A and B, a class of cyclic 
lipodepsipeptides isolated from a Pseudomonas species. Acta Crystallogr. C 2002, 58, 268–271. 
50.  Sinnaeve, D.; Hendrickx, P.M.; Van Hemel, J.; Peys, E.; Kieffer, B.; Martins, J.C. The solution 
structure and self-association properties of the cyclic lipodepsipeptide pseudodesmin A support 
its pore-forming potential. Chemistry 2009, 15, 12653–12662. 
51.  Guenzi, E.; Galli, G.; Grgurina, I.; Gross, D.C.; Grandi, G. Characterization of the syringomycin 
synthetase gene cluster. A link between prokaryotic and eukaryotic peptide synthetases. J. Biol. 
Chem. 1998, 273, 32857–32863. 
52.  Sorensen,  K.N.;  Kim,  K.H.;  Takemoto,  J.Y.  In  vitro  antifungal  and fungicidal  activities and 
erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. 
syringae. Antimicrob. Agents Chemother. 1996, 40, 2710–2713. 
53.  Ballio, A.; Bossa, F.; Collina, A.; Gallo, M.; Iacobellis, N.S.; Paci, M.; Pucci, P.; Scaloni, A.; 
Segre,  A.;  Simmaco,  M.  Structure  of  syringotoxin,  a  bioactive  metabolite  of  Pseudomonas 
syringae pv. syringae. FEBS Lett. 1990, 269, 377–380. 
54.  Harrison, L.; Teplow, D.B.; Rinaldi, M.; Strobel, G. Pseudomycins, a family of novel peptides 
from Pseudomonas syringae possessing broad-spectrum antifungal activity. J. Gen. Microbiol. 
1991, 137, 2857–2865. 
55.  Scaloni, A.; Dalla Serra, M.; Amodeo, P.; Mannina, L.; Vitale, R.M.; Segre, A.L.; Cruciani, O.; 
Lodovichetti, F.; Greco, M.L.; Fiore, A.; Gallo, M.; D’Ambrosio, C.; Coraiola, M.; Menestrina, 
G.;  Graniti,  A.;  Fogliano,  V.  Structure,  conformation  and  biological  activity  of  a  novel 
lipodepsipeptide from Pseudomonas corrugata: cormycin A. Biochem. J. 2004, 384, 25–36. 
56.  Morikawa, M.; Daido, H.; Takao, T.; Murata, S.; Shimonishi, Y.; Imanaka, T. A new lipopeptide 
biosurfactant produced by Arthrobacter sp. strain MIS38. J. Bacteriol. 1993, 175, 6459–6466. 
57.  Henriksen, A.; Anthoni, U.; Nielsen, T.H.; Sorensen, J.; Christophersen, C.; Gajhede, M. Cyclic 
lipoundecapeptide  tensin  from  Pseudomonas  fluorescens  strain  96.578.  Acta  Crystallogr.  C 
2000, 56 (Pt 1), 113–115. 
58.  Kuiper,  I.;  Lagendijk,  E.L.;  Pickford,  R.;  Derrick,  J.P.;  Lamers,  G.E.;  Thomas-Oates,  J.E.; 
Lugtenberg,  B.J.;  Bloemberg,  G.V.  Characterization  of  two  Pseudomonas  putida  lipopeptide Int. J. Mol. Sci. 2011, 12                       
 
 
165 
biosurfactants,  putisolvin  I  and  II,  which  inhibit  biofilm  formation  and  break  down  existing 
biofilms. Mol. Microbiol. 2004, 51, 97–113. 
59.  Bassarello, C.; Lazzaroni, S.; Bifulco, G.; Lo Cantore, P.; Iacobellis, N.S.; Riccio, R.; Gomez-
Paloma, L.; Evidente, A. Tolaasins A-E, five new lipodepsipeptides produced by Pseudomonas 
tolaasii. J. Nat. Prod. 2004, 67, 811–816. 
60.  Ballio, A.; Bossa, F.; Camoni, L.; Di Giorgio, D.; Flamand, M.C.; Maraite, H.; Nitti, G.; Pucci, 
P.; Scaloni, A. Structure of fuscopeptins, phytotoxic metabolites of Pseudomonas fuscovaginae. 
FEBS Lett. 1996, 381, 213–216. 
61.  Emanuele, M.C.; Scaloni, A.; Lavermicocca, P.; Jacobellis, N.S.; Camoni, L.; Di Giorgio, D.; 
Pucci,  P.;  Paci,  M.;  Segre,  A.;  Ballio,  A.  Corpeptins,  new  bioactive  lipodepsipeptides  from 
cultures of Pseudomonas corrugata. FEBS Lett. 1998, 433, 317–320. 
62.  Ballio, A.; Barra, D.; Bossa, F.; Collina, A.; Grgurina, I.; Marino, G.; Moneti, G.; Paci, M.; 
Pucci, P.; Segre, A.; et al. Syringopeptins, new phytotoxic lipodepsipeptides of Pseudomonas 
syringae pv. syringae. FEBS Lett. 1991, 291, 109–112. 
63.  Ballio, A.; Bossa, F.; Di Giorgio, D.; Di Nola, A.; Manetti, C.; Paci, M.; Scaloni, A.; Segre, A.L. 
Solution conformation of the Pseudomonas syringae pv. syringae phytotoxic lipodepsipeptide 
syringopeptin 25-A. Two-dimensional NMR, distance geometry and molecular dynamics. Eur. J. 
Biochem. 1995, 234, 747–758. 
64.  Scaloni,  A.;  Camoni,  L.;  di  Giorgio,  D.;  Scortichini,  M.;  Cozzolino,  R.;  Ballio,  A.  A  new 
syringopeptin produced by a Pseudomonas syringae pv syringae strain isolated from diseased 
twigs of laurel. Physiol. Mol. Plant Pathol. 1997, 51, 259–264. 
65.  Vallet-Gely, I.; Novikov, A.; Augusto, L.; Liehl, P.; Bolbach, G.; Pechy-Tarr, M.; Cosson, P.; 
Keel,  C.;  Caroff,  M.;  Lemaitre,  B.  Association  of  hemolytic  activity  of  Pseudomonas 
entomophila,  a  versatile  soil  bacterium,  with  cyclic  lipopeptide  production.  Appl.  Environ. 
Microbiol. 2010, 76, 910–921. 
66.  Gross, H.; Stockwell, V.O.; Henkels, M.D.; Nowak-Thompson, B.; Loper, J.E.; Gerwick, W.H. 
The genomisotopic approach: a systematic method to isolate products of orphan biosynthetic 
gene clusters. Chem. Biol. 2007, 14, 53–63. 
67.  Janek, T.; Lukaszewicz, M.; Rezanka, T.; Krasowska, A. Isolation and characterization of two 
new lipopeptide biosurfactants produced by Pseudomonas fluorescens BD5 isolated from water 
from the Arctic Archipelago of Svalbard. Bioresour. Technol. 2010, 101, 6118–6123. 
68.  Berti, A.D.; Greve, N.J.; Christensen, Q.H.; Thomas, M.G. Identification of a biosynthetic gene 
cluster  and  the  six  associated  lipopeptides  involved  in  swarming  motility  of  Pseudomonas 
syringae pv. tomato DC3000. J. Bacteriol. 2007, 189, 6312–6323. 
69.  Cosmina, P.; Rodriguez, F.; de Ferra, F.; Grandi, G.; Perego, M.; Venema, G.; van Sinderen, D. 
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis. 
Mol. Microbiol. 1993, 8, 821–831. 
70.  Roongsawang, N.; Lim, S.P.; Washio, K.; Takano, K.; Kanaya, S.; Morikawa, M. Phylogenetic 
analysis of condensation domains in the nonribosomal peptide synthetases. FEMS Microbiol. 
Lett. 2005, 252, 143–151. Int. J. Mol. Sci. 2011, 12                       
 
 
166 
71.  Kraas, F.I.; Helmetag, V.; Wittmann, M.; Strieker, M.; Marahiel, M.A. Functional dissection of 
surfactin  synthetase  initiation  module  reveals  insights  into  the  mechanism  of  lipoinitiation. 
Chem. Biol. 2010, 17, 872–880. 
72.  Schneider, A.; Marahiel, M.A. Genetic evidence for a role of thioesterase domains, integrated in 
or associated with peptide synthetases, in non-ribosomal peptide biosynthesis in Bacillus subtilis. 
Arch. Microbiol. 1998, 169, 404–410. 
73.  Schwarzer,  D.;  Mootz,  H.D.;  Linne,  U.;  Marahiel,  M.A.  Regeneration  of  misprimed 
nonribosomal peptide synthetases by type II thioesterases. Proc. Natl. Acad. Sci. USA 2002, 99, 
14083–14088. 
74.  Yeh, E.; Kohli, R.M.; Bruner, S.D.; Walsh, C.T. Type II thioesterase restores activity of a NRPS 
module stalled with an aminoacyl-S-enzyme that cannot be elongated. ChemBioChem 2004, 5, 
1290–1293. 
75.  Menkhaus, M.; Ullrich, C.; Kluge, B.; Vater, J.; Vollenbroich, D.; Kamp, R.M. Structural and 
functional organization of the surfactin synthetase multienzyme system.  J. Biol. Chem. 1993, 
268, 7678–7684. 
76.  Steller,  S.;  Sokoll,  A.;  Wilde,  C.;  Bernhard,  F.;  Franke,  P.;  Vater,  J.  Initiation  of  surfactin 
biosynthesis and the role of the SrfD-thioesterase protein. Biochemistry 2004, 43, 11331–11343. 
77.  Vanittanakom,  N.; Loeffler, W.;  Koch, U.; Jung, G. Fengycin-a novel  antifungal  lipopeptide 
antibiotic produced by Bacillus subtilis F-29-3. J. Antibiot. (Tokyo) 1986, 39, 888–901. 
78.  Rivardo, F.; Turner, R.J.; Allegrone, G.; Ceri, H.; Martinotti, M.G. Anti-adhesion activity of two 
biosurfactants  produced  by  Bacillus  spp.  prevents  biofilm  formation  of  human  bacterial 
pathogens. Appl. Microbiol. Biotechnol. 2009, 83, 541–553. 
79.  Thaniyavarn, J.; Roongsawang, N.; Kameyama, T.; Haruki, M.; Imanaka, T.; Morikawa, M.; 
Kanaya, S. Production and characterization of biosurfactants from Bacillus licheniformis F2.2. 
Biosci. Biotechnol. Biochem. 2003, 67, 1239–1244. 
80.  Wu,  C.Y.;  Chen,  C.L.;  Lee,  Y.H.;  Cheng,  Y.C.;  Wu,  Y.C.;  Shu,  H.Y.;  Gotz,  F.;  Liu,  S.T. 
Nonribosomal synthesis  of fengycin  on an enzyme complex formed by fengycin synthetases.  
J. Biol. Chem. 2007, 282, 5608–5616. 
81.  Leclere, V.; Marti, R.; Bechet, M.; Fickers, P.; Jacques, P. The lipopeptides mycosubtilin and 
surfactin enhance spreading of Bacillus subtilis strains by their surface-active properties. Arch. 
Microbiol. 2006, 186, 475–483. 
82.  Tsuge, K.; Akiyama, T.; Shoda, M. Cloning, sequencing, and characterization of the iturin A 
operon. J. Bacteriol. 2001, 183, 6265–6273. 
83.  Moyne, A.L.; Cleveland, T.E.; Tuzun, S. Molecular characterization and analysis of the operon 
encoding the antifungal lipopeptide bacillomycin D. FEMS Microbiol. Lett. 2004, 234, 43–49. 
84.  Hansen, D.B.; Bumpus, S.B.; Aron, Z.D.; Kelleher, N.L.; Walsh, C.T. The loading module of 
mycosubtilin: an adenylation domain with fatty acid selectivity. J. Am. Chem. Soc. 2007, 129, 
6366–6367. 
85.  Aron,  Z.D.;  Fortin,  P.D.;  Calderone,  C.T.;  Walsh,  C.T.  FenF:  servicing  the  mycosubtilin 
synthetase assembly line in trans. ChemBioChem 2007, 8, 613–616. Int. J. Mol. Sci. 2011, 12                       
 
 
167 
86.  Aron, Z.D.; Dorrestein, P.C.; Blackhall, J.R.; Kelleher, N.L.; Walsh, C.T. Characterization of a 
new tailoring domain in polyketide biogenesis: the amine transferase domain of MycA in the 
mycosubtilin gene cluster. J. Am. Chem. Soc. 2005, 127, 14986–14987. 
87.  Dittmann,  J.;  Wenger,  R.M.;  Kleinkauf,  H.;  Lawen,  A.  Mechanism  of  cyclosporin  A 
biosynthesis. Evidence for synthesis via a single linear undecapeptide precursor. J. Biol. Chem. 
1994, 269, 2841–2846. 
88.  Walton, J.D. Two enzymes involved in biosynthesis of the host-selective phytotoxin HC-toxin. 
Proc. Natl. Acad. Sci. USA 1987, 84, 8444–8447. 
89.  Balibar, C.J.; Vaillancourt, F.H.; Walsh, C.T. Generation of D amino acid residues in assembly 
of arthrofactin by dual condensation/epimerization domains. Chem. Biol. 2005, 12, 1189–1200. 
90.  Gross,  H.;  Loper,  J.E.  Genomics  of  secondary  metabolite  production  by  Pseudomonas  spp.  
Nat. Prod. Rep. 2009, 26, 1408–1446. 
91.  Hutchison, M.L.; Gross, D.C. Lipopeptide phytotoxins produced by Pseudomonas syringae pv. 
syringae: comparison of the biosurfactant and ion channel-forming activities of syringopeptin 
and syringomycin. Mol. Plant Microbe Interact. 1997, 10, 347–354. 
92.  Guenzi, E.; Galli, G.; Grgurina, I.; Pace, E.; Ferranti, P.; Grandi, G. Coordinate transcription and 
physical linkage of domains in surfactin synthetase are not essential for proper assembly and 
activity of the multienzyme complex. J. Biol. Chem. 1998, 273, 14403–14410. 
93.  Vaillancourt, F.H.; Yin, J.; Walsh, C.T. SyrB2 in syringomycin E biosynthesis is a nonheme FeII 
alpha-ketoglutarate-  and  O2-dependent  halogenase.  Proc.  Natl.  Acad.  Sci.  USA  2005,  102, 
10111–10116. 
94.  Singh,  G.M.;  Vaillancourt,  F.H.;  Yin,  J.;  Walsh,  C.T.  Characterization  of  SyrC,  an 
aminoacyltransferase  shuttling  threonyl  and  chlorothreonyl  residues  in  the  syringomycin 
biosynthetic assembly line. Chem. Biol. 2007, 14, 31–40. 
95.  Singh, G.M.; Fortin, P.D.; Koglin, A.; Walsh, C.T. beta-Hydroxylation of the aspartyl residue in 
the phytotoxin syringomycin E: characterization of two candidate hydroxylases AspH and SyrP 
in Pseudomonas syringae. Biochemistry 2008, 47, 11310–11320. 
96.  Scholz-Schroeder, B.K.; Soule, J.D.; Gross, D.C. The sypA, sypB, and sypC synthetase genes 
encode twenty-two modules involved in the nonribosomal peptide synthesis of syringopeptin by 
Pseudomonas syringae pv. syringae B301D. Mol. Plant Microbe Interact. 2003, 16, 271–280. 
97.  Ikegami, T. Osaka University, Osaka, Japan. Personal communication, 2004. 
98.  Roongsawang, N.; Hase, K.; Haruki, M.; Imanaka, T.; Morikawa, M.; Kanaya, S. Cloning and 
characterization  of  the  gene  cluster  encoding  arthrofactin  synthetase  from  Pseudomonas  sp. 
MIS38. Chem. Biol. 2003, 10, 869–880. 
99.  Andersen, J.B.; Koch, B.; Nielsen, T.H.; Sorensen, D.; Hansen, M.; Nybroe, O.; Christophersen, 
C.; Sorensen, J.; Molin, S.; Givskov, M. Surface motility in Pseudomonas sp. DSS73 is required 
for efficient biological containment of the root-pathogenic microfungi Rhizoctonia solani and 
Pythium ultimum. Microbiology 2003, 149, 37–46. 
100.  Roongsawang,  N.;  Washio,  K.;  Morikawa,  M.  Hokkaido  University,  Hokkaido,  Japan. 
Unpublished work, 2007. Int. J. Mol. Sci. 2011, 12                       
 
 
168 
101.  Roongsawang, N.; Washio,  K.; Morikawa, M.  In vivo characterization of tandem C-terminal 
thioesterase domains in arthrofactin synthetase. ChemBioChem 2007, 8, 501–512. 
102.  Lim, S.P.; Roongsawang, N.; Washio, K.; Morikawa, M. Functional analysis of a pyoverdine 
synthetase from Pseudomonas sp. MIS38. Biosci. Biotechnol. Biochem. 2007, 71, 2002–2009. 
103.  Saini, H.S.; Barragan-Huerta, B.E.; Lebron-Paler, A.; Pemberton, J.E.; Vazquez, R.R.; Burns, 
A.M.; Marron, M.T.; Seliga, C.J.; Gunatilaka, A.A.; Maier, R.M. Efficient purification of the 
biosurfactant viscosin from Pseudomonas libanensis strain M9-3 and its physicochemical and 
biological properties. J. Nat. Prod. 2008, 71, 1011–1015. 
104.  Kruijt,  M.; Tran, H.; Raaijmakers, J.M.  Functional,  genetic and chemical  characterization of 
biosurfactants produced by plant growth-promoting Pseudomonas putida 267. J. Appl. Microbiol. 
2009, 107, 546–556. 
105.  Dubern,  J.F.;  Coppoolse,  E.R.;  Stiekema,  W.J.;  Bloemberg,  G.V.  Genetic  and  functional 
characterization  of  the  gene  cluster  directing  the  biosynthesis  of  putisolvin  I  and  II  in 
Pseudomonas putida strain PCL1445. Microbiology 2008, 154, 2070–2083. 
106.  Magnuson,  R.;  Solomon,  J.;  Grossman,  A.D.  Biochemical  and  genetic  characterization  of  a 
competence pheromone from Bacillus subtilis. Cell 1994, 77, 207–216. 
107.  Auchtung,  J.M.;  Lee,  C.A.;  Grossman,  A.D.  Modulation  of  the  ComA-dependent  quorum 
response in Bacillus subtilis by multiple Rap proteins and Phr peptides. J. Bacteriol. 2006, 188, 
5273–5285. 
108.  Roggiani,  M.;  Dubnau,  D.  ComA,  a  phosphorylated  response  regulator  protein  of  Bacillus 
subtilis, binds to the promoter region of srfA. J. Bacteriol. 1993, 175, 3182–3187. 
109.  Yakimov,  M.M.;  Golyshin,  P.N.  ComA-dependent  transcriptional  activation  of  lichenysin  A 
synthetase promoter in Bacillus subtilis cells. Biotechnol. Prog. 1997, 13, 757–761. 
110.  Griffith, K.L.; Grossman, A.D. A degenerate tripartite DNA-binding site required for activation 
of ComA-dependent quorum response gene expression in Bacillus subtilis. J. Mol. Biol. 2008, 
381, 261–275. 
111.  Wang,  X.;  Luo,  C.;  Liu,  Y.;  Nie,  Y.;  Zhang,  R.;  Chen,  Z.  Three  non-aspartate  amino  acid 
mutations in the ComA Response regulator receiver motif severely decrease surfactin production, 
competence  development  and  spore  formation  in  Bacillus  subtilis.  J.  Microbiol.  Biotechnol. 
2010, 20, 301–310. 
112.  Nakano, M.M.; Zuber, P. Cloning and characterization of srfB, a regulatory gene involved in 
surfactin production and competence in Bacillus subtilis. J. Bacteriol. 1989, 171, 5347–5353. 
113.  Kim, S.B.; Shin, B.S.; Choi, S.K.; Kim, C.K.; Park, S.H. Involvement of acetyl phosphate in the 
in vivo activation of the response regulator ComA in Bacillus subtilis. FEMS Microbiol. Lett. 
2001, 195, 179–183. 
114.  Cosby, W.M.; Vollenbroich, D.; Lee, O.H.; Zuber, P. Altered srf expression in Bacillus subtilis 
resulting from changes in culture pH is dependent on the Spo0K oligopeptide permease and the 
ComQX system of extracellular control. J. Bacteriol. 1998, 180, 1438–1445. 
115.  Hayashi, K.; Ohsawa, T.; Kobayashi, K.; Ogasawara, N.; Ogura, M. The H2O2 stress-responsive 
regulator PerR positively regulates srfA expression in Bacillus subtilis. J. Bacteriol. 2005, 187, 
6659–6667. Int. J. Mol. Sci. 2011, 12                       
 
 
169 
116.  Nakano, M.M.; Zhu, Y.; Liu, J.; Reyes, D.Y.; Yoshikawa, H.; Zuber, P. Mutations conferring 
amino acid residue substitutions in the carboxy-terminal domain of RNA polymerase alpha can 
suppress  clpX  and  clpP  with  respect  to  developmentally  regulated  transcription  in  Bacillus 
subtilis. Mol. Microbiol. 2000, 37, 869–884. 
117.  Mader, U.; Antelmann, H.; Buder, T.; Dahl, M.K.; Hecker, M.; Homuth, G. Bacillus subtilis 
functional genomics: genome-wide analysis of the DegS-DegU regulon by transcriptomics and 
proteomics. Mol. Genet. Genomics 2002, 268, 455–467. 
118.  Hayashi,  K.; Kensuke, T.;  Kobayashi,  K.; Ogasawara, N.; Ogura, M.  Bacillus  subtilis  RghR 
(YvaN) represses rapG and rapH, which encode inhibitors of expression of the srfA operon. Mol. 
Microbiol. 2006, 59, 1714–1729. 
119.  Ogura, M.; Fujita, Y. Bacillus subtilis rapD, a direct target of transcription repression by RghR, 
negatively regulates srfA expression. FEMS Microbiol. Lett. 2007, 268, 73–80. 
120.  Ohsawa, T.; Tsukahara, K.; Sato, T.; Ogura, M. Superoxide stress decreases expression of srfA 
through inhibition of transcription of the comQXP quorum-sensing locus in Bacillus subtilis.  
J. Biochem. 2006, 139, 203–211. 
121.  Serror,  P.;  Sonenshein,  A.L.  CodY  is  required  for  nutritional  repression  of  Bacillus  subtilis 
genetic competence. J. Bacteriol. 1996, 178, 5910–5915. 
122.  Nakano, S.; Nakano, M.M.; Zhang, Y.; Leelakriangsak, M.; Zuber, P. A regulatory protein that 
interferes with activator-stimulated transcription in bacteria. Proc. Natl. Acad. Sci. USA 2003, 
100, 4233–4238. 
123.  Reyes, D.Y.; Zuber, P. Activation of transcription initiation by Spx: formation of transcription 
complex and identification of a cis-acting element required for transcriptional activation. Mol. 
Microbiol. 2008, 69, 765–779. 
124.  Quadri, L.E.; Weinreb, P.H.; Lei, M.; Nakano, M.M.; Zuber, P.; Walsh, C.T. Characterization of 
Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in 
peptide synthetases. Biochemistry 1998, 37, 1585–1595. 
125.  Tsuge, K.; Ohata, Y.; Shoda, M. Gene yerP, involved in surfactin self-resistance in Bacillus 
subtilis. Antimicrob. Agents Chemother. 2001, 45, 3566–3573. 
126.  Tsuge, K.; Ano, T.; Hirai, M.; Nakamura, Y.; Shoda, M. The genes degQ, pps, and lpa-8 (sfp) are 
responsible for conversion of Bacillus subtilis 168 to plipastatin production. Antimicrob. Agents 
Chemother. 1999, 43, 2183–2192. 
127.  Msadek, T.; Kunst, F.; Klier, A.; Rapoport, G. DegS-DegU and ComP-ComA modulator-effector 
pairs control expression of the Bacillus subtilis pleiotropic regulatory gene degQ. J. Bacteriol. 
1991, 173, 2366–2377. 
128.  Tsuge, K.; Ano, T.; Shoda, M. Isolation of a gene essential for biosynthesis of the lipopeptide 
antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8. Arch. Microbiol. 1996, 165, 243–251. 
129.  Ke, W.J.; Chang, B.Y.; Lin, T.P.; Liu, S.T. Activation of the promoter of the fengycin synthetase 
operon by the UP element. J. Bacteriol. 2009, 191, 4615–4623. 
130.  Duitman, E.H.; Wyczawski, D.; Boven, L.G.; Venema, G.; Kuipers, O.P.; Hamoen, L.W. Novel 
methods  for  genetic  transformation  of  natural  Bacillus  subtilis  isolates  used  to  study  the Int. J. Mol. Sci. 2011, 12                       
 
 
170 
regulation of the mycosubtilin and surfactin synthetases. Appl. Environ. Microbiol. 2007, 73, 
3490–3496. 
131.  Koumoutsi,  A.;  Chen,  X.H.;  Vater,  J.;  Borriss,  R.  DegU  and  YczE  positively  regulate  the 
synthesis  of  bacillomycin  D  by  Bacillus  amyloliquefaciens  strain  FZB42.  Appl.  Environ. 
Microbiol. 2007, 73, 6953–6964. 
132.  Huang, C.C.; Ano, T.; Shoda, M. Nucleotide sequence and characteristics of the gene, lpa-14, 
responsible for biosynthesis of the lipopeptide antibiotics iturinA and surfactin from Bacillus 
subtilis RB14. J. Ferment. Bioeng. 1993, 76, 445–450. 
133.  Heeb, S.; Haas, D. Regulatory roles of the GacS/GacA two-component system in plant-associated 
and other gram-negative bacteria. Mol. Plant Microbe Interact. 2001, 14, 1351–1363. 
134.  Workentine, M.L.; Chang, L.; Ceri, H.; Turner, R.J. The GacS-GacA two-component regulatory 
system  of  Pseudomonas  fluorescens:  a  bacterial  two-hybrid  analysis.  FEMS  Microbiol.  Lett. 
2009, 292, 50–56. 
135.  Willis, D.K.; Holmstadt, J.J.; Kinscherf, T.G. Genetic evidence that loss of virulence associated 
with gacS or gacA mutations in Pseudomonas syringae B728a does not result from effects on 
alginate production. Appl. Environ. Microbiol. 2001, 67, 1400–1403. 
136.  Koch, B.; Nielsen, T.H.; Sorensen, D.; Andersen, J.B.; Christophersen, C.; Molin, S.; Givskov, 
M.;  Sorensen,  J.;  Nybroe,  O.  Lipopeptide  production  in  Pseudomonas  sp.  strain  DSS73  is 
regulated  by  components  of  sugar  beet  seed  exudate  via  the  Gac  two-component  regulatory 
system. Appl. Environ. Microbiol. 2002, 68, 4509–4516. 
137.  Nielsen,  T.H.;  Nybroe,  O.;  Koch,  B.;  Hansen,  M.;  Sorensen,  J.  Genes  involved  in  cyclic 
lipopeptide production are important for seed and straw colonization by Pseudomonas sp. strain 
DSS73. Appl. Environ. Microbiol. 2005, 71, 4112–4116. 
138.  Dubern, J.F.; Bloemberg, G.V. Influence of environmental conditions on putisolvins I and II 
production in Pseudomonas putida strain PCL1445. FEMS Microbiol. Lett. 2006, 263, 169–175. 
139.  Dubern, J.F.; Lugtenberg, B.J.; Bloemberg, G.V. The ppuI-rsaL-ppuR quorum-sensing system 
regulates biofilm formation of Pseudomonas putida PCL1445 by controlling biosynthesis of the 
cyclic lipopeptides putisolvins I and II. J. Bacteriol. 2006, 188, 2898–2906. 
140.  Washio, K.; Lim, S.P.; Roongsawang, N.; Morikawa, M. Identification and characterization of 
the genes responsible for the production of the cyclic lipopeptide arthrofactin by Pseudomonas 
sp. MIS38. Biosci. Biotechnol. Biochem. 2010, 74, 992–999. 
141.  Dubern, J.F.; Lagendijk, E.L.; Lugtenberg, B.J.; Bloemberg, G.V. The heat shock genes dnaK, 
dnaJ, and grpE are involved in regulation of putisolvin biosynthesis in Pseudomonas putida 
PCL1445. J. Bacteriol. 2005, 187, 5967–5976. 
142.  Wang, N.; Lu, S.E.; Records, A.R.; Gross, D.C. Characterization of the transcriptional activators 
SalA  and  SyrF,  Which  are  required  for  syringomycin  and  syringopeptin  production  by 
Pseudomonas syringae pv. syringae. J. Bacteriol. 2006, 188, 3290–3298. 
143.  de Bruijn, I.; Raaijmakers, J.M. Diversity and functional analysis of LuxR-type transcriptional 
regulators  of  cyclic  lipopeptide  biosynthesis  in  Pseudomonas  fluorescens.  Appl.  Environ. 
Microbiol. 2009, 75, 4753–4761. Int. J. Mol. Sci. 2011, 12                       
 
 
171 
144.  de Bruijn, I.; Raaijmakers, J.M. Regulation of cyclic lipopeptide biosynthesis in Pseudomonas 
fluorescens by the ClpP protease. J. Bacteriol. 2009, 191, 1910–1923. 
145.  Srivatsan,  A.;  Wang,  J.D.  Control  of  bacterial  transcription,  translation  and  replication  by 
(p)ppGpp. Curr. Opin. Microbiol. 2008, 11, 100–105. 
146.  Finking,  R.;  Solsbacher,  J.;  Konz,  D.;  Schobert,  M.;  Schafer,  A.;  Jahn,  D.;  Marahiel,  M.A. 
Characterization of a new type of phosphopantetheinyl transferase for fatty acid and siderophore 
synthesis in Pseudomonas aeruginosa. J. Biol. Chem. 2002, 277, 50293–50302. 
147.  Barekzi, N.; Joshi, S.; Irwin, S.; Ontl, T.; Schweizer, H.P. Genetic characterization of pcpS, 
encoding  the  multifunctional  phosphopantetheinyl  transferase  of  Pseudomonas  aeruginosa. 
Microbiology 2004, 150, 795–803. 
148.  Seidle,  H.F.;  Couch, R.D.; Parry, R.J. Characterization of a nonspecific phosphopantetheinyl 
transferase from Pseudomonas syringae pv. syringae FF5. Arch. Biochem. Biophys. 2006, 446, 
167–174. 
149.  Quigley,  N.B.;  Mo,  Y.Y.;  Gross,  D.C.  SyrD  is  required  for  syringomycin  production  by 
Pseudomonas syringae pv. syringae and is related to a family of ATP-binding secretion proteins. 
Mol. Microbiol. 1993, 9, 787–801. 
150.  Grgurina, I.; Gross, D.C.; Iacobellis, N.S.; Lavermicocca, P.; Takemoto, J.Y.; Benincasa, M. 
Phytotoxin production by Pseudomonas syringae pv. syringae: Syringopeptin production by syr 
mutants defective in biosynthesis or secretion of syringomycin. FEMS Microbiol. Lett. 1996, 
138, 35–39. 
151.  Kang,  H.;  Gross,  D.C.  Characterization  of  a  resistance-nodulation-cell  division  transporter 
system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae. Appl. 
Environ. Microbiol. 2005, 71, 5056–5065. 
152.  Lim, S.P.; Roongsawang, N.; Washio, K.; Morikawa, M. Flexible exportation mechanisms of 
arthrofactin in Pseudomonas sp. MIS38. J. Appl. Microbiol. 2009, 107, 157–166. 
153.  Kobayashi,  N.;  Nishino,  K.;  Yamaguchi,  A.  Novel  macrolide-specific  ABC-type  efflux 
transporter in Escherichia coli. J. Bacteriol. 2001, 183, 5639–5644. 
154.  Schneider, A.; Stachelhaus, T.; Marahiel, M.A. Targeted alteration of the substrate specificity of 
peptide synthetases by rational module swapping. Mol. Gen. Genet. 1998, 257, 308–318. 
155.  Yakimov,  M.M.;  Giuliano,  L.;  Timmis,  K.N.;  Golyshin,  P.N.  Recombinant  acylheptapeptide 
lichenysin: high level of production by  Bacillus subtilis cells. J. Mol. Microbiol. Biotechnol. 
2000, 2, 217–224. 
156.  de Ferra, F.; Rodriguez, F.; Tortora, O.; Tosi, C.; Grandi, G. Engineering of peptide synthetases. 
Key role of the thioesterase-like domain for efficient production of recombinant peptides. J. Biol. 
Chem. 1997, 272, 25304–25309. 
157.  Trauger,  J.W.;  Kohli,  R.M.;  Mootz,  H.D.;  Marahiel,  M.A.;  Walsh,  C.T.  Peptide  cyclization 
catalysed by the thioesterase domain of tyrocidine synthetase. Nature 2000, 407, 215–218. 
158.  Kohli, R.M.; Trauger, J.W.; Schwarzer, D.; Marahiel, M.A.; Walsh, C.T. Generality of peptide 
cyclization  catalyzed  by  isolated  thioesterase  domains  of  nonribosomal  peptide  synthetases. 
Biochemistry 2001, 40, 7099–7108. Int. J. Mol. Sci. 2011, 12                       
 
 
172 
159.  Stachelhaus, T.; Mootz, H.D.; Marahiel, M.A. The specificity-conferring code of adenylation 
domains in nonribosomal peptide synthetases. Chem. Biol. 1999, 6, 493–505. 
160.  Uguru, G.C.; Milne, C.; Borg, M.; Flett, F.; Smith, C.P.; Micklefield, J. Active-site modifications 
of  adenylation  domains  lead  to  hydrolysis  of  upstream  nonribosomal  peptidyl  thioester 
intermediates. J. Am. Chem. Soc. 2004, 126, 5032–5033. 
161.  Mootz, H.D.; Kessler, N.; Linne, U.; Eppelmann, K.; Schwarzer, D.; Marahiel, M.A. Decreasing 
the ring size of a cyclic nonribosomal peptide antibiotic by in-frame module deletion in the 
biosynthetic genes. J. Am. Chem. Soc. 2002, 124, 10980–10981. 
162.  Symmank,  H.;  Franke,  P.;  Saenger,  W.;  Bernhard,  F.  Modification  of  biologically  active 
peptides: production of a novel lipohexapeptide after engineering of Bacillus subtilis surfactin 
synthetase. Protein Eng. 2002, 15, 913–921. 
163.  Butz, D.; Schmiederer, T.; Hadatsch, B.; Wohlleben, W.; Weber, T.; Sussmuth, R.D. Module 
extension  of  a  non-ribosomal  peptide  synthetase  of  the  glycopeptide  antibiotic  balhimycin 
produced by Amycolatopsis balhimycina. ChemBioChem 2008, 9, 1195–1200. 
164.  Hahn, M.; Stachelhaus, T. Harnessing the potential of communication-mediating domains for the 
biocombinatorial synthesis  of nonribosomal peptides.  Proc. Natl. Acad. Sci. USA 2006, 103, 
275–280. 
165.  Chiocchini, C.; Linne, U.; Stachelhaus, T. In vivo biocombinatorial synthesis of lipopeptides by 
COM domain-mediated reprogramming of the surfactin biosynthetic complex. Chem. Biol. 2006, 
13, 899–908. 
166.  Vater,  J.;  Wilde,  C.;  Kell,  H.  In  situ  detection  of  the  intermediates  in  the  biosynthesis  of 
surfactin, a lipoheptapeptide from Bacillus subtilis OKB 105, by whole-cell cell matrix-assisted 
laser desorption/ionization time-of-flight mass spectrometry in combination with mutant analysis. 
Rapid. Commun. Mass Spectrom. 2009, 23, 1493–1498. 
167.  Ackerley, D.F.; Lamont, I.L. Characterization and genetic manipulation of peptide synthetases in 
Pseudomonas aeruginosa PAO1 in order to generate novel pyoverdines. Chem. Biol. 2004, 11, 
971–980. 
168.  Baltz, R.H. Biosynthesis and genetic engineering of lipopeptides in Streptomyces roseosporus. 
Methods Enzymol. 2009, 458, 511–531. 
169.  Nguyen, K.T.; He, X.; Alexander, D.C.; Li, C.; Gu, J.Q.; Mascio, C.; Van Praagh, A.; Mortin, L.; 
Chu, M.; Silverman, J.A.; Brian, P.; Baltz, R.H. Genetically engineered lipopeptide antibiotics 
related to A54145 and daptomycin with improved properties. Antimicrob. Agents Chemother. 
2010, 54, 1404–1413. 
©  2010  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 